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Preface 
I. Aim of the study. 
The starting point for this thesis was the observation that when attempts are made to 
separate monoferric transferrins from diferric transferrin by isoelectric focusing, in 
addition to what was thought to represent the pure monoferric transferrins, a great 
number of additional bands are found whose presence cannot be explained by 
differences in iron content. Treatment of serum samples with sialidase before isoelectric 
focusing decreases the number of additional bands. This variability in electrophoretic 
behaviour can be quantified by comparing relative amounts of components as measured 
through crossed immunoelectrophoresis after separation by isoelectric focusing. From a 
screening experiment it appeared that different patterns could be obtained in a number 
of pathological conditions 1, which led us to further investigate this phenomenon. 
2. The work. 
The first step was a literature survey on what we anticipated to be the biochemical basis 
for the phenomenon of microheterogeneity2·3 : the N-glycosylation of proteins. Based on 
this literature survey we decided to first ascertain that differences in N-glycosylation 
indeed underlie the microheterogeneity of transferrin. To this end amino acid and 
carbohydrate analyses were performed on protein samples obtained by preparative 
isoelectric focusing 4• The results confirmed the above mentioned assumption and 
consequently also validated our speculations as to the structure of the glycans ascribed 
to the different microheterogeneous forms. 
Extending the initial work on transferrin microheterogeneity in serum samples, we 
found characteristic changes in the microheterogeneity pattern in a wide variety of 
patient and volunteer groups. Ideas on the physiological role of modulation of N-
glycosylation were developed on the basis of the direction of changes in the context of 
current knowledge about iron metabolism in the pathophysiological conditions 
explicitly or implicitly defined by these groups5 
Testing these hypotheses was possible after we developed a method to isolate uniquely 
defined transferrin subfractions6• Singularly defined microheterogeneous forms of 
transferrin were then characterised with reference to the role of transferrin in iron 
metabolism by incubation experiments on the cells most intimately involved in iron 
metabolism; i.e. hepatocytes, placental membrane and bone marrow7• On the basis of 
our findings and the literature on transferrin metabolism, a hypothesis explaining both 
the role of microheterogeneity in iron metabolism and the mechanism of mobilisation of 
iron stores in pregnancy and iron deficiency and the acute phase reactions is 
forwarded7. 
Extending this work on structure function relationships with particular reference to N-
glycosylation, we attempted step by step removal of sugar residues from glycans still 
attached to the protein core, but this failed because procedures yielded either 
unchanged transferrin or irreversibly denatured protein. Thus, an alternative approach 
was chosen. Since bacteria are not capable of N-glycosylation, the approach has been to 
induce expression of transferrin in E. coli by recombinant DNA-techniques. This work 
has been performed in close collaboration with us by one of our colleagues in the 
department, Drs. M.J. de Smit, at the Gorlaeus laboratory in Leiden, and as a result we 
ii 
have been able to obtain human transferrin with its authentic amino acid sequence, but 
without theN-linked glycans8·9 
3. Future prospects 
Medical colleagues often wondered why I bothered for something which did not seem 
lack anything except clinical relevance. Entangled as I was in the intricacies of protein 
glycosylation I found myself unable to provide a satisfactory answer. Now studies on 
the biochemistry underlying microheterogeneity have given us more insights into the 
role of this phenomenon in health and disease, but the holy grail of clinical relevance 
defined as conclusions with direct implications for diagnosis or treatment may not be 
apparent from our work. A future path to clinical relevance lies in the exciting new 
proposals for the use of transferrin in cancer chemotherapy and in the use of 
microheterogeneity patterns as diagnostic aids. Both these applications rely on basic 
research; the availability of recombinant transferrins will enable us to investigate in 
more detail structure function relationships, hopefully create new insights in iron 
metabolism and transferrin metabolism, and possibly implement this knowledge in the 
future. 
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General introduction 
Transferrin in the context of iron homeostasis 
Nomenclature and historical perspective 
General Considerations 
Transferrin in the context of iron homeostasis 
The earth's core consists for the major part of iron, and amongst metals in the earth's crust it is 
second only to aluminum 1• As a result, abundant supplies of both ferrous and ferric iron are 
present in the biosphere, which is suitable for iron is an absolutely essential nutrient for 
virtually all forms of life examined ( the lactobacillus is one of the very few organisms known 
not to require iron for growth2 ). Paradoxically, despite the propitious geological starting point, 
without exception organisms have to rely on ingenious methods for uptake and transport of 
iron. This is due to the fact that in the present oxidizing atmosphere in aqueous solutions Fe(IIl) 
is the thermodynamically favoured iron species. The consequent physiological conditions 
complicate the availability of iron to both plant and animal cells, i.e. the extremely low 
solubility of ferric ions in oxygenated fluids at neutral pH ( 10-17 mol/1) and the fact that cell 
membranes are essentially impermeable to iron in its trivalent state. Hence, for the transport of 
iron in both aqueous and lipid phases special requirements must be met. The solutions acquired 
by different species involve organic chelates such as ferric citrate, or for plants ferric galate, 
and for bacteria siderophore chelates. In animals, and this also applies to a few parasitic 
protozoa and bacteria, transferrin and possibly also ferritin supply the bulk of the iron to the 
cell surface. Little information on the nature of the transmembranous and intracellular transport 
vehicles is available. Current research points to an important role for low molecular weight 
fractions, notably physiological cell components such as A TP and ascorbate3.4, but their 
concomitant or consecutive roles in transport to and from iron binding proteins and iron 
containing enzymes have not been clarified. 
Once intracellular storage is remarkably uniform. From bacteria through fungi to the animal and 
plant kingdoms, iron is stored in its ferrrous form as a polynuclear (FeOOH)8(FeO-OPOJH2) -
core within a protein shell composed of a number of ferritin molecules5. In this form the 
organism is protected from participation of the ferrous iron in toxic oxidation-reduction 
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reactions, but remains capable of mobilising these iron stores on demand. 
Most of the recent progress in the understanding of iron metabolism has been derived from 
advances in the research of the iron binding proteins ferritin, lactoferrin and transferrin. In this 
thesis my effort to contribute to the understanding of transferrin and iron metabo1ism is 
described. 
Nomenclature and historical perspective 
The transferrins form a group of evolutionary related proteins. Members of the group 
{synonyms between brackets) are: 
I. Transferrin (siderophilin), a metal-binding B-globulin of vertebrate blood plasma and 
other extracellular fluids, such as milk, semen, amniotic fluid, cerebrospinal fluid 
(tau-protein, myotrophic factor; sciatin ). Transcripts from the same gene are also 
found in bird and reptile oviduct secretions and egg whites ( ovotransferrin or 
conalbumin ). 
2. Lactoferrin (}acto-transferrin ) of mammalian extracellular secretions (milk, 
pancreatic juice, tears) and intracellular in leukocytes. 
3. Malignancy associated transferrins and pseudogenes p97, an integral membrane 
protein of human malignant melanoma cells and some foetal tissues 
( melanotransferrin, genuine transferrin), chicken lymphoma ChBlym-l transforming 
protein, Burkitt lymphoma transforming protein. 
4. Invertebrate iron binding proteins in the blood of some crustaceae and urochordates. 
This somewhat confounding nomenclature of these iron binding proteins is best understood in 
the light of the history of iron and transferrin research. 
The use of iron-containing substances to relieve the symptoms of an.emia has been an 
established empiric fact dating back to pre-Egyptian history. The first scientific facts on the role 
of iron in living organisms were registered in 1713 by Lemrnery and Geoffroy who 
demonstrated the presence of iron in animal tissues 11 • In 1843 J. Liebig published his book 
Tierchemie. In the chapter on respiration he proposed that all oxidation of biological substrates 
occurred in the blood; in his view the iron contained in haemoglobin played a central role in 
this process. This view was adopted by many of his contemporary scientists, amongst others by 
Hoppe-Seyler who was the first to isolate haemoglobin in purified crystalline form in 1867. 
After microspectroscopic examination of slices of animal muscle tissue under oxidizing and 
reducing conditions, McMunn in 1866 forwarded the view that all tissues contained pigments 
that were involved in cellular respiration implying that haem-containing proteins were not 
restricted to erythrocytes alone, but present in all living cells7 . Conflicting with the intravascular 
oxidation theory of Liebig his view was sharply criticised by Hoppe-Seyler and his followers in 
the years after, with the result that McMunn's hypothesis was discarded. Unintentionally, in 
perpetuating the idea that all iron in blood was contained in haemoglobin this also blunted 
initiatives to rejuvenate research into the nature of iron found in plasma. 
Advances in the understanding of cellular respiration initiated by the work of Otto Warburg 
around 1910 ("Eisen, den sauerstoff-ubertragenden Bestandteil des Atmungsferment") and 
the rediscovery of Me Munn's findings by Keilin with the demonstration of iron in the haem-
containing proteins that became known as cytochromes in cells other than erythrocytes in the 
1920's, not only eventually lead to the conception and elucidation of the structure of the 
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respiratory chain but also reopened the discussion on iron transport in the body. 
In 1925 Fontes and Thivolle demonstrated that iron in blood plasma was not identical to iron in 
haernoglobin8, a finding for which they coined the term fer circulant. In 1927 this was 
corroborated by Barkan9 who added to this the notion that this iron was bound to a substance of 
high molecular weight from which it could not easily be separated at physiological pH by 
dialysis. On the other hand the iron could easily be separated by mild acidification (as opposed 
to the more brusque methods needed to separate iron from intracellular haem-proteins ), and in 
turn he named it das Ieicht abspaltbares Bluteisens. In 1937 Barkan and Schales were able to 
establish that the high molecular substance involved was a globular proteinw (incidentally both 
articles were published in Hoppe-Seyler's Zeitung fi.ir Physiologische Chemie ). 
This high molecular weight substance was considered to play an important role in iron 
metabolism, but unequivocal correlation of the limited laboratory findings with clinical 
conditions was not possible. Interested in this subject L. Heilmeyer and coworkers investigated 
therapeutic effects of iron salts in anemia from 1936 on 11 , and in 1945 Holmberg and Laurell 
tried to correlate the iron binding capacity of serum with iron transport 12 , but evidence for the 
importance of transferrin in iron metabolism was difficult to obtain. Heilmeyer was rewarded 
for his longstanding interest in iron metabolism in 1961 with the discovery of a patient 
suffering from a severe anemia with the characteristics of iron deficiency despite having high 
liver iron stores (and repeated infections ). This patient provided what is still simply the 
ultimate certification of the importance of transferrin in iron homeostasis (and health in 
general ), for this was the first patient identified as suffering from the extremely rare condition 
of atransferrinemia !3. 
The nomenclature for iron binding proteins in body fluids has evolved from early clinical 
chemistry. The first iron binding protein of this class was detected in milk in 1939. This protein 
was later shown to be produced not only by epithelia in lactating glands but also by epithelia 
producing sweat, tears, saliva and pancreatic juice and to be present intracellularly in 
leucocytes, particularly increasing in acute phase responses. This protein has been named 
lactoferrin and is a protein with many structural similarities to transferrin, but not identical to it. 
In 1944 Schade and Caroline observed an inhibitory influence of an iron binding protein 
isolated from eggwhite on the growth of Shigella species 14 . This eggwhite protein was called 
conalbumin and later shown to be identical to ovotransferrin. Recently it has been established 
that both liver and oviduct transferrin are transcribed from the same gene. Regulation of gene 
transcription in these tissues is dissimilar, the endproduct is nevertheless an identical 
polypeptide. Finai!y, in 1946 Schade and Caroline were able to demonstrate similar 
bacteriostatic properties for an iron binding protein isolated from plasrna15 . This protein 
isolated from plasma they named siderophylin. Although one could argue that in the light of 
current understanding this is a more appropriate name, it was the name forwarded by Laurel! 
and Holmberg in 1947 16 that has become the most commonly used, probably because it reflects 
its role ln iron metabolism more explicitly: transferrin. 
The latest intriguing addition to the transferrin family is the P 97, also known as 
melanotransferrin since it was first identified in a malignant melanoma-derived cell Iine. This 
protein has one characteristic that sets it apart from the other transferrins: it is an integral 
membrane protein. Moreover, despite elaborate efforts 17 , to date an active role in iron transport 
has yet to be identified for this protein. 
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General Considerations 
Transferrins are monomeric glycoproteins found in the biological fluids of invertebrates and 
vertebrates, with the property of reversibly binding iron18· 19 • Transferrin is believed to regulate 
iron-fluxes between sites of absorption, storage and utilisation, the most important in the last 
respect being the bone marrow. Full understanding of the functions of transferrin has not been 
achieved. Its presence in culture media is probably essential for the growth of cultured cells that 
do not synthesise transferrin themselves 19-21 . This indispensability of transferrin may extend to 
all chordates, since invariably animals belonging to three of the classes of the Phylum Chordata 
( Reptilia, Aves and Mammalia ) have been shown to carry transferrins in their blood, or 
comparable body fluids 22• Also primitive vertebrates such as the lamprey23 , the hagfish24·25 and 
the tench26, have monomeric transferrin-like molecules with two iron binding sites and a 
molecular mass of approximately 78,000 Dalton. The Lamprey Geotria australis Gray has a 
tetrarneric form made out of four 78,000 Dalton subunits with two iron-binding sites per 
subunit27 • Xenopus species have also been shown to have transferrin-like molecules with a 
molecular weight of about 85,000 Dalton28 • Even in cases of so-called atransferrinemia, trace 
amounts of transferrin can be detected29·30, suggesting that absolute atransferrinemia is incom-
patible with life. It is not yet clear which function of transferrin is responsible for this 
indispensability-phenomenon. In some culture systems it appears to be independent of the iron 
donating capacity of transferrin. Conceivably this is related to the recently described interaction 
of transferrin with the transplasmalemma NADH reductase (chapter 4 ). 
Tetra-sialo Penta-sialo Hexa-sialo transferrin 
Legend: a=GLcNAc O=Man e=Gal O=NAcNeu 
figure 1. Schematic representation of the transferrin molecule carrying two N-linked glycans in the C-
terminal domain. Three microheterogeneous forms of human transferrin are shown at the 
bottom of the figure. 
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In humans, transferrin is one of the most extensively studied plasma proteins. The aminoacid 
sequence of human serum transferrin, the localisation of the gene ( q21-25, long arm 
chromosome 3 ) and many of its structural features including the complete base sequence, have 
been established31•34. Minor differences exist between the aminoacid sequence predicted from 
the nucleotide sequence of eDNA probes and the chemically determined aminoacid sequence, 
which is a usual finding when comparing results of dissimilar sequence analysis techniques. 
Most of the differences relate to the existence or absence of ami dation of side chains, but none 
of the differences has direct implications on secondary structural features such as disulphide 
bridges and glycosylation sites. 
Human transferrin consists of a single polypeptide chain containing 679 aminoacid residues 
carrying two N-linked complex type glycan chains. For apotransferrin the calculated molecular 
mass is 79,570 Dalton, of which 4,412 Dalton ( 5,5 %) can be accounted for by two complex 
type biantennary glycans. Some physicochemical data on transferrin are given in Table I. 
Table 1. Aminoacid composition of human serum transferrin and physicochemical 
properties32•33.35. The amino acid values have been based on the eDNA characterization 
by Yang et al31 
Aminoacid moVmol 
Property Apotransferrin Diferric 
Transferrin 
Lysine 58 
Histidine 19 
Arginine 26 
Aspartate 45 Molecular Mass 79,570 79,898 
Threonine 30 Sedimentation constant so 20,w. (± 0.2) 5.4 5.16 
Serine 41 
Glutamate 43 Stokes radius 3.53 nm 3.58 nm 
Proline 32 Intrinsic viscosity (mUg) 4.10 ± 0.15 4.05 ± 0.15 
Glycine 50 Axial ratio (prolate ellipsoid ) 2.5 2 
Alanine 57 Hydrated Volume(cm:SJ 15.4 X 10-:LU 16.9 X to·LU 
Cysteine 38 
Valine 45 Molar absorption coefficient 280 nm 88,200 114,000 
Methionine 9 470nm - 4620 
Isoleucine 15 lsoelectric points ( 4-sialo Tf cl ) 5.80 5.45 
Leucine 59 Eo Fe(ll)/Fe(l!D -310 mV 
Tyrosine 26 
Phenylalanine 28 Iron binding sites: 
Asparagine 34 
Glutamine 16 Number 2 
Tryptophan 8 Ka ( pH=7.4) 
N-terminal domain 1 ·10UM-1 
Total 679 C-terminal domain 6· 1022 M-1 
The transferrin molecule can be divided into two homologous domains, theN-terminal domain 
(residues 1-336) and the C-terminal domain (residues 337-679) with the carbohydrate 
moieties in the C-terminal domain at positions 413 and 611 ( Figure I ). The presence of two 
domains with a high degree of internal homology ( up to 40% ) in the transferrin molecule has 
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been demonstrated by partial proteolysis of a number of transferrin species, producing 
fragments containing about half the polypeptide and a single metal-binding site36"3s and by 
aminoacid sequence studies32 • Low resolution X-ray crystallographic studies of rabbit serum 
transferrin have shown that the polypeptide chain is folded into two globular domains 39 • These 
observations were extended by 0.32 nm X-ray diffraction-analysis of the iron saturated human 
lactoferrin40• This study showed that the N- and C-terminal halves form two separate globular 
lobes, each of which has two segments surrounding a cleft. At the base of these clefts, hidden 
below the surface of the molecule, the specific iron binding sites are located. 
A comparable situation is thought to exist in human serum transferrin. The molecule is divided 
in two globular domains, each containing one metal-binding site, binding a ferric ion with a Ka 
of approximately 1022 M- 1. The concomitant binding of an anion (physiologically bicarbonate) 
is essential for metal binding at each site. Although iron is the most important metal bound by 
transferrin in vivo, transferrins are capable of binding over 20 metal ions including Cr3+, Cu2+, 
Mn2+, Co3+, Co2+, Cd2+, Zn2+, Ga3+, Ni2+, AJ3+, Sc3+, In3+, and Gd3+, albeit that the affinity for 
most of these ions is less than that for Fe3+. Nevertheless in the circulation trace elements such 
as aluminum and zinc are located predominantly in the transferrin fraction. and as such 
transferrin plays an important role in the homeostasis of these elements. 
The two iron binding sites are virtually independent since the affinity of either site for iron 
changes little with occupancy of the other. This does not mean that there is no biophysical 
difference between the binding sites. At pH 6. 7, the affinity for iron at the binding-site in the N-
terminal domain is less than one-twentieth the affinity for iron the binding-site located in the C-
terminal domain. Hence the binding site in the C-termina] domain has been termed the 
acid-stable site. Under conditions prevailing in the circulation, the effective affinity constants of 
theN- and C-site amount to 1 and 6 x 1022 M-1 respective1ll.42 . Recently these parameters have 
been extended in the pH-range physiological in the endosomes involved in receptor mediated 
endocytosis. The denominations acid-stable and acid-labile sites of receptor-bound transferrin 
at that pH are incorrect since it is the N-terminal domain displaying the higher affinity then, a 
fact that highlights an additional role for the receptor itself in iron transport (see paragraph on 
iron uptake, chapter 4 ). 
The bilobed structure together with the existence of a high degree of internal homology 
between the two domains has led to the hypothesis that all modern, vertebrate ( bilobed ) 
transferrins arose during the course of evolution by duplication and fusion of a gene specifying 
a simpler single-domain protein. This gene-duplication hypothesis is supported by a number of 
other structural features. The chicken ovotransferrin gene and the human transferrin gene 
display a high degree of homology between pairs of exons of the individual genes and simila-
rities in splicing patterns in corresponding exon pairs3 1.33.43, consistent with the proposed gene 
duplication. Also, as suggested by Williams, the conservative disposition of the disulphide 
bridges reinforces this idea44 • 
Two theories on the characteristics of the archetypal unilobed transferrin later involved in the 
gene duplication have been proposed. In both theories the duplication of this primordial gene 
offers the biological advantage of production of a bilobed, enlarged transferrin molecule. This 
enlargement prevents loss of transferrin through glomerular ultrafiltration with loss of both iron 
and protein through urinary excretion. Indeed, isolated domains of hen transferrin injected into 
the circulation of mice are rapidly excreted in the urine45. 
In the first theory a freely circulating single lobe transferrin is envisioned to have been the 
predecessor. Such a molecule has been claimed to exist in a primitive urochordate46 : An iron-
binding protein with a molecular mass of about 41,000 Dalton and one iron binding-site, 
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capable of donating iron to rat reticulocytes through binding to the transferrin receptor and 
subsequent endocytosis. The urochordate referred to, Pyura stolonifera, allegedly lacked the 
evolutionary drive to exclude the mono-sited ancestor because this animal does not possess a 
filtration kidney and is thus capable of holding a transferrin of smaller molecular size. Whether 
this substance is truly a transferrin is questionable, since one of the pertinent characteristics of 
all bilobed transferrins, the concomitant binding of a bicarbonate ion upon the binding of a 
ferric ion is lacking in this protein ( P. Aisen, personal communication). 
Williams has postulated that the ancestral transferrin gene may have arisen in urochordates as a 
cell membrane-anchored 40,000 dalton protein44 • As indicated above sustained existence in the 
circulation would be impossible. Therefore the anchorage may have enabled it to serve as a 
membrane-associated iron receptor. The membrane bound tumour antigen P97 is homologous 
to transferrin and binds iron. P97 can thus be viewed as the rudimentary witness of that 
evolutionary stage where duplication of the gene had already occurred, but before the protein 
had gained entrance to the blood stream. Other characteristics of the melanotransferrin that 
would argue in favour of this proposition are the highest internal homolgy of all transferrins 
( 46 % as opposed to values ranging from 33 to 41 % ), the location of its gene also on 
chromosome 3, and the 37- 39 %sequence homology with human serum transferrin, lactoferrin 
and chicken transferrin. However, even though a large number of membrane iron binding sites 
were identified in the melanoma derived cell line that expresses the melanotransferrin on its 
surface ( 387,000 per cell), and although the melanotransferrin is capable of binding ferric iron 
offered to it in the form of ferric citrate, intracellular uptake from this membrane bound iron 
pool could not be detected17 • 
Thus, the gene-duplication theory as such is generally appreciated, but the question of the 
origin of the bilobed transferrin remains. 
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Chapter 2. 
I Control of transferrin synthesis 
The principal site of synthesis of transferrin that enters the circulation is the hepatocyte. Other 
cells shown to constitutively produce transferrin are Sertoli cells, brain capillary endothelial 
cells, ependymal cells in the choroid plexus, and oligodendroglia! cells in the brain. During 
lactation, from a quantitative point of view, the mammary gland is also an important transferrin 
source. From a qualitative point of view transferrin production in testis and brain is interesting. 
By virtue of respectively the haematotesticular and the blood brain barrier in these organs a 
distinct extracellular environment is created. Despite the lack of high iron requirements, 
transferrrin is still an essential element in these compartments, explaining the need for local 
production of transferrin albeit at slower rates than in the liver (estimated at one tenth the rate 
in the liver). This tissue-specific expression is the result of the interaction of different sets of 
nuclear binding proteins with cis-acting elements in the transferrin gene in each organ4H 9. 
Tissue-specific transferrin gene expression inevitably starts at and discloses itself through the 
fetal and embryonal stages. During rat embryogenesis, transferrin has been shown to be 
synthesized by a variety of embryonic and extra-embryonic cells. The visceral yolksac is the 
major source of transferrin in the early gestational period. Later on, the foetal liver shows the 
highest level of Tf-mRNA expression. Tf-mRNA can also be detected in spleen and kidney of 
the rat embryo5051 . This temporal control during development is further developed after birth. 
Transferrin synthesis in kidney, muscle and spleen progressively diminishes after birth. In the 
brain and testis transferrin mRNA-levels are very low in the fetal stages but increase 
significantly after birth, eventually reaching about 10% of the level attained in liver tissue, and 
this is maintained throughout adult life. Although it has not been possible to test this 
proposition in brain tissue, the idea is that in these particular organs transferrin is one of the 
components that are added by these matrix-defining cells to the microenvironment that is 
essential for normal function of these organs. This is derived from the observation that the 
beginning of spermatogenesis coincides with the detectability of transferrin in the testis 
following production of transferrin mRNA in Sertoli cells and the fact that normal 
differentiation of germinal cells depends on the presence of transferrin, indicating that the 
ability to synthesise transferrin becomes restricted to certain cell types depending on the 
particular developmental pathway. As Zakin noted49 this does not imply that tissue-specific 
expression of transferrin is restricted to one embryological origin. Hepatocytes arise from 
endoderm, Sertoli cells from the mesoderm and nervous cells from the ectoderm, implicitly 
illustrating the importance of transferrin to the organism at all levels. 
The concentration of serum transferrin is regulated by a complex interplay of factors .Increased 
synthesis can be realised at transcriptional as well as at translational levels. 
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5' flanking sequence transferrin-gene: 
RNA 
start site 
DRII DR! CR PRII PRI ----7 
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-3600 Bp -3300Bp -1000 Bp -620 Bp -l25Bp -45Bp 
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PRI&PRII 
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Figure 2. Current view on regulatory principles in transferrin gene transcription. Tissue specific transcription is 
defined by the existence of particular subsets of DNA-binding proteins in particular cell lineages. Levels are further 
adapted through DNA-binding protein-dependent modulation of enhancer activity which is the result of interactions in 
distal promoter and the far distal enhancer element. Tf mRNA-levels in Sertoli cells for instance being 1/10 th of liver 
levels due to the lack of blockage of distal negative acting element. Since low levels of transferrin are detected in the 
plasma of individuals with so called atransferrinemia, this affliction may be related to alterations in either the distal 
enhancer or the distal negative acting region consequently blocking hepatic enhancement of basal production levels. 
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The concentration of transferrin in human serum is increased during iron-deficiency anaemia 
and pregnancy, and is decreased in hemochromatosis. Steroid hormones have been shown to 
stimulate Tf-mRNA and transferrin protein synthesis in chick liver and oviduct and in rat 
liver51-53 , while at the same time Tf-mRNA levels in brain, testis, spleen and kidney were not 
enhanced. In nutritional iron deficiency mRNA levels increased in chicken and rat liver, but not 
in oviduct. Catabolism of serum transferrin did not change in iron deficiency. Iron overload did 
not influence transferrin gene transcription. 
In contrast, Tuil and co-workers were unable to demonstrate a stimulatory effect of either 
castration, estradiol administration or iron deficiency in the raf4 . They suggested that the 
regulation of transferrin concentration in serum in response to an altered body iron status is not 
primarily a transcriptional event. Since no overt methodological differences are described, no 
explanation for this disagreement is available. Metal responsive elements in the promoter 
region of the transferrin gene have been shown to exist34·55·56, but the mechanisms involved in 
transcriptional and translational regulation of the transferrin synthesis in response to iron 
deficiency have not been fully elucidated. With respect to regulation of cellular iron uptake the 
transferrin receptor may be more important, since its gene expression has been shown to be 
much more sensitive to intracellular iron concentration than transferrin gene expression57-60. The 
expression of the transferrin receptor gene is not directly enhanced; the effect appears to be 
attained through iron responsive elements in the untranslated region of the mRNA that 
modulate mRNA stability"·62. 
Returning to the issue of tissue-specific transferrin expression, much information has become 
available since the elucidation of the complete structure of the transferrin gene33 . The gene as 
such is located on chromosome 3 ( together with the transferrin receptor and the 
melanotransferrin gene). It consists of 17 exons and 16 introns preceded by regulatory 
sequences as described in figure 2. 
Transcription being one of the central points at which eucaryotic gene expression is regulated, 
much research into the nature of these regulatory elements has been done. Presently, four 
distinct functional regions in the 5' flanking region of the gene have been identified: 
1. Tissue specificity regulating proximal promotor region, 
2. Distal promotor region regulating proximal promotor activity, 
3. Negative acting region, downregulating transcription from the transferrin promoter, 
4. Distally located enhancer element. 
Since no deletion in the proximal promoter region could convert a hepatoma-specific region 
into one that was active in a non-hepatocellular cell line, it has been concluded that liver tissue 
specificity must result from a liver specific stimulus56 . Distinct DNA-binding proteins have 
been shown to exist for both positive acting elements in the proximal promoter region. The 
distal promoter region is composed of a combination of possibly three positive and two 
negative acting elements. Most of them have been shown to interact with DNA-binding prote-
ins3456. A third region has been identified, distal to the promoter region. Deletion of this part of 
the 5'-flanking sequence gave rise to a transcriptional increase, implying a negative regulatory 
role for this sequence. Finally, a fourth, far distal region in the 5'- flanking region of the trans-
ferrin gene has been identified as an enhancer region. The current view on the organisation of 
regulatory elements involved in transferrin gene expression is given in_figure 2. 
Summarising the scheme, expression of the transferrin gene to a certain level is authorised by 
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positive acting elements in the proximal promoter region in response to tissue specific DNA 
binding proteins. Through the expression of these proteins, tissue specificity of transferrin gene 
transcription is regulated. This provides certain cell types with a basal level of expression that 
is further modified by the interaction of both tissue specific and ubiquitous DNA-binding 
proteins with distal promotor and enhancer regions, that ultimately define the tissue-specific 
level of transferrin gene transcription. 
A total of nine elements distributed over four regions in the 5'-flanking region of the transferrin 
gene have presently been implicated in transferrin gene expression. Simultaneous interaction of 
a number of nuclear binding proteins is a general mechanism required to ensure high specificity 
of the transcription control signal as nonspecific binding of regulatory proteins is not 
inconceivable in large genomes. The relatively high number may be the reflection of the status 
of this gene: a highly conserved gene cautiously tuned to diverse physiological demands. 
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Chapter 3. 
Chemical determinants of electrophoretic behaviour 
First determinant 
Second determinant 
Third determinant 
Miscellaneous factors 
For many years it has been recognised that immunoaffinity-purified transferrin 
displays a complex electrophoretic behaviour indicating that transferrin is not a 
homogeneous substance. In the past years a great number of studies has elucidated the 
structural basis of transferrin heterogeneity and as a result three main categories of 
causes can now be considered (figure 3 ): 
1. Variation in the polypeptide chain; genetically determined aminoacid 
substitutions or deletions. 
2. Differences in iron content. 
3. Differences in the structure of theN-linked glycan chains. 
First determinant 
The first determinant of electrophoretic behaviour, genetic polymorphism, is best revealed after 
neuraminidase treatment and saturation of serum with iron. Genetic polymorphism of plasma 
transferrin was first described by Smithies employing starch gel electrophoresis for 
separation63 . At least 22 functional variants have been detected by starch or agarose gel 
electrophoresis. The most common phenotype (more than 95% in European populations) has 
been designated TfC, the more anodal (faster running) variants Tffi, and the more cathodal 
(slower) TID. Phenotypes within the main groups are designated by subscripts ( TfDChl, 
TfD1, etc. ). The aminoacid substitutions in some of these variants have been determined and 
were shown to be single aminoacid substitutions. Each of these could be explained by a 
mutational transition in the second nucleotide of the involved codon31 Until 1978 TfC was 
considered to be a single variant. However using isoelectric focusing ( IEF ), TfC was shown to 
consist of two subtypes; TfC1 and TfC264•65 . Subsequently additional C-variants have been 
detected by IEF, the total number of C-variants is now claimed to be 1666·67 . Also a number of 
null alleles have been detected in various populations30·68-70. In most of these cases, transferrin 
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synthesis is not completely blocked, suggesting distal mutations affecting the distal promotor 
enhancing element ( figure 2 ). 
The degree of transferrin polymorphism in most populations has therefore spuriously increased 
to about 29%. Although distributions in different populations vary, of all 38 or more variants 
only 4 occur with a frequency over 1%67• Most Tf-variants show the same iron binding capacity as 
the common type TfC. An unusual human transferrin having abnormal iron binding properties 
and an abnormal interaction with the transferrin receptor has been identified7L72 • 
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Figure 3. Transferrin microheterogeneity of an individual with the C1C2 genotype as in principle 
detectable by isoelectric focusing. (A) Total number of bands in untreated serum. (B) Major 
bands in untreated serum as revealed by isoelectric focusing in carrier ampholyte gels, 
corresponding to tetrasialotransferrins that can be separated on the basis of differences in iron 
content. (C) Microheterogeneous forms of transferrin that can be distinguished in an iron-
saturated serum sample. (D) Reduction of the total number of72 bands to 2 by saturation with 
iron and neuraminidase treatment of the serum sample, a procedure useful in the assessment 
of genotypic variation. 
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Moreover even the common C-alleles have been shown to differ in their iron binding capacities: 
the iron binding capacity of transferrin from subjects with the 1-1 subtype of TfC is signifi 
cantly higher than that of the 2-2 subtype, as well as that of the 2-1 subtype73 . Reports about the 
increased prevalence of TfC2 and TfC3 in preterm infants and the increased frequency of the 
C2-allele and especially of the C2-type among women with a history of spontaneous 
abortion 74·76 have suggested the possibility that other functions than its iron carrying capacity 
may also be influenced by genetic polymorphism. 
One might relate this to still the most striking general observation on the prevalence of 
transferrin variants: From Eskimos to Aboriginals, the C 1 subspecies has been identified as the 
oustanding predominant transferrin, suggesting a strong selectional advantage. 
Second determinant 
A second factor determining the electrophoretic behaviour of transferrin is the iron content. 
Under physiological conditions serum transferrin is approximately 30% saturated with iron. 
Consequently, employing techniques such as urea gel electrophoresis 77 and isoelectric 
focusing78, in fresh serum four different forms of transferrin with respect to the iron content can 
be distinguished and isolated: apotransferrin, Tf; monoferric transferrin with iron in the N-
terminal domain, FeN Tf; monoferric transferrin with iron in the C-terminal domain, TfFec; and 
diferric transferrin, Fe2 Tf. 
The question whether the two iron binding-sites serve different physiological purposes in vivo79 
is still uncertain. The predominance of FeN Tf over TfFec in sera from healthy donors41.n78.so, 
despite the uniformity of these transferrins in in vitro systems and in vivo with respect to their 
iron donating behaviour81"83 is the basis of this uncertainty. The predominance of FeN Tf over 
TfFec in serum is a generally accepted concept. However, one group of researchers has 
unremittingly disputed the non random distribution of iron among the two binding-sites of 
serum transferrin in both healthy individuals84 and patients with haematological disorders~5 . 
Finally, although those in favour of the non-random distribution by far outnumber those 
denying it, it may be that the controversy lingers on simply because all groups have been 
studying an artefact. This is considered in the light of the observation that the distribution of 
iron can be altered by storage of serum samples at -80°C86. Confirming this, we have observed 
a shift from non random to random distribution upon prolonged storage of serum samples at -
20 "C. 
An essential feature with respect to the role of transferrin in iron metabolism is the fact that it 
has been shown that the transferrin receptor has greater affinity for diferric transferrin than for 
either monoferric transferrins or apotransfemin. This and the fact that apoTf has low affinity 
for the transferrin receptor at physiological pH and a high affinity at a low pH, are key 
properties in the model explaining both the recycling of transferrin after receptor mediated 
endocytosis and the high effectiveness with respect to iron donation of this system8n 8_ 
Third determinant 
The third determinant of the electrophoretic behaviour of transferrin is the carbohydrate moiety. 
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Jamieson noted the influence of protein linked oligosaccharide structure on electrophoretic 
mobility in 1965. In performing starch gel electrophoresis on transferrin samples treated with 
neuraminidase, 4 components appear successively89 . The normal occurrencence of such diverse 
forms defined by differences in glycan structure in serum samples was not be noted by him. 
This phenomenon, nowadays termed microheterogeneity, has become detectable after the 
introduction of more powerful electrophoretic separation techniques, notably the isoelectric 
focusing90• 
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Transferrin carries two oligosaccharide chains in the N-terminal domain. These branched 
chains referred to as glycans are covalently linked to Asparagine residues. As the glycan is 
linked through the nitrogen atom in the R group of Asparagine these structures are referred to 
as N-linked glycans. Oligosaccharide chains of different composition, but in many cases also 
carrying sialic acid as the ultimate residue, linked through oxygen in the R groups of Serine or 
Threonine, also exist in glycoproteins. These so called 0-linked glycans are however not found 
in transferrin. 
The two N-linked oligosaccharide chains of transferrin have been shown to be structurally 
variable91"93 . Glycans can differ in their degree of branching since bi-antennary, tri-, tetra- and 
even penta-antennary structures have been shown to exist (figure 4 ). Apart from this they can 
also differ in their terminal sugar residues. Glycans can be partially desialylated or even lack 
galactose or N-acetyl glucosamine residues. It has been proposed and accepted as an axiom that 
the structure of two (or more) glycans on one protein molecule was uniform ( Kerkaert-Bayart 
proposal ). This has been disproved; one molecule may carry differently branched glycans. 
The biosynthetic machinery responsible for this structural diversity is interwoven with protein 
synthesis and in particular linked to those compartments that supply the matrix for the system 
involved in the synthesis of proteins that are destined to be excreted or incorporated in the cell 
membrane: the rough endoplasmic reticulum and the Golgi system. ( For an elaborate 
description of the biochemical and cell biological basis of glycoprotein microheterogeneity the 
reader is referred to reviews listed numbers 94-98 in the references-section ). 
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Transferrin synthesis starts with the association of the mRNA and ribosomes in the cytoplasm. 
The transferrin polypeptide chain formed initially is nineteen amino acids longer than the final 
molecule. Before secretion these aminoacids are excised by proteolytic enzymes99·100. The 
shortening of the initial translation product seems to be obligatory because inhibition of this 
event prevents secretion. This restricted element likely entails the signal moiety necessary for 
translocation of the mRNA-ribosome-complex from the cytoplasm to the rough endoplasmic 
reticulum (figure 7 ). On the other hand, inhibition of glycosylation does not prevent secreti-
on99_ 
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Figure 6. Structure of the four major types of N-linked glycans. The boxed areas enclose the 
pentasccharide core common to all N-li~ed glycans. Adapted from reference 96. 
N-Glycosylation of proteins is initiated in the rough endoplasmic reticulum (RER) by the 
synthesis of a lipid intermediate, dolichol-pyrophosphoryl-oligosaccharide, with stepwise 
addition of sugar residues from activated donor substrates (Figure 5 ). Next, the complete 
lipid-linked precursor is tranferred in a single step either to the polypeptide as it is being 
synthesized and extruded into the lumen of the RER, or after completion of polypeptide 
synthesis. The membrane associated oligosaccharyltransferase linking the oligosaccharide to 
the polypeptide is highly specific and transfer will be carried out only to asparagine-residues in 
the sequence Asn-X-Serffhr(Cys), where X may be any aminoacid other than proline or 
aspartic acid. In general, due to steric constraints only one third of all possible glycosylation 
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sites are involved in glycopeptide linkage. In the case of human transferrin, two possible 
glycosylation sites are available and both are utilized. 
Up to this point a direct specific coding system is operational, positioning a uniform glycan on 
specific sites only. The third phase of N-glycan biosynthesis involves the processing and 
subsequent elongation of the oligosaccharide chains to their final form by the sequential, and in 
some cases mutually exclusive action of a number of highly specific glucosidases, 
mannosidases and glycosyl-, phosphoryl- and sulfotransferases as the glycoprotein passes 
through the different compartments of the Golgi system (Figure 7 ). 
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Figure 7. Biosynthesis of glycan chains in the RER and Golgi apparatus. + Sialic acid 
• mannose, o galactose Ill N-acetyl glucosamine, A glucose . 
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It is in this last phase that glycan heterogeneity is produced, affecting all of the carbohydrate 
chain except the core structure containing 3-D-mannose and 2-N-acetyl-D-glucosamine 
residues common to all N-linked oligosaccharides (Figure 6,7 ). There is a wide but limited 
array of possible structures for complex type oligosaccharide chains ( Figure 8 ). A 
generalisation that can be made is the distinction of four separate classes of N-linked 
oligosaccharides: the high mannose, complex, hybrid and poly-N-acetyl-lactosamino-glycan 
types ( Figure 6). 
S.A. 
a2.3or6 I 
Gal Gal 
!!1,41 (11.4 1 
'"' 
NA~Giuc NAcGluc 
a1.3 I "I ", 
S.A. 
C< 2,R I 
Fuc S.A. 
a 1.2or 6 I ""I 
Gal Go> 
!11,41 6 1,4 1 
NAcGluc NAcGiuc 
", I "I 
' 
....._____ / 
NAcGluc 
!!1.4 I 
A<n 
Go> 
C<1.31 
Gal 
",, I 
NAcGiuc 
"'I 
' 6 ~/ 
M~ /cxl,6 
So-> 
, I 
GaiNAc 
l\1,4 I 
NAcGiuc 
" I 
S.A. 
jo. 2.3nr4 
Gal 
lll.3 I 
NAcGtuc --S.A 
"'I 0. 2,6 
Figure 8. Outer chain sequences found in complex type N-linked glycans. Abbreviations: Man 
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S.A.: sialic acid, S04: sulphuric acid. The common pentasaccharide core is contained in the boxed area. 
Transferrin contains two complex type oligosaccharide chains, differing in degree of branching 
and terminal carbohydrate composition. This microheterogeneity is due to the fact that glycan 
synthesis does not take place via an accurate template mechanism, like DNA and polypeptide 
synthesis. Since instead its synthesis depends on a highly complex and vulnerable orchestration 
of interactions between glycosyltransferases, glycosidases, polypeptides, differential 
distribution of enzymes and differential substrate availability, some room for variability is a 
logical consequence. Illustrating this it can be worked out94 that while 3 molecules of the same 
aminoacid can form only one tripeptide, in contrast, taking in account differences in the 
anomeric configuration and position of the glycosidic bonds, 3 molecules of the same hexose 
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can form 176 different trisaccharides. Considering the complexity of the synthetic pathways 
involved, the oligosaccharide structures attached to a particular protein (which generally 
consist of II - 15 components) show surprisingly little variation. 
The factors determining which type of glycan a protein will possess at a particular site have not 
yet been fully determined. The polypeptide moiety itself probably has a strong directional 
influence. This influence is further modified by changes in the biochemical environment 
because when glycoprotein genes are expressed in different eukaryotic cells, the processing of 
starting glycan yields different final structures. A great deal of control is nevertheless exerted 
on the biosynthetic mechanisms involved in glycan synthesis, since within each different 
lineage the outcome itself appears to be uniform. 
The question still remains whether microheterogeneity is nevertheless a random process with 
little functional significance. In other words, does microheterogeneity represent "biochemical 
noise", or does it play a more important role in the organism. 
Miscellaneous factors 
A number of additional causes of structural variation have been recognised. Like all proteins 
transferrin is susceptible to nonenzymatic deamidation which will cause anodal displacement. 
Deamidation is not influenced by the aforementioned causes of heterogeneity with the 
exception of genetic mutations that lead to changes in the amounts of asparagine or glutamine. 
The extent to which deamidated transferrins are present in blood is unknown. On close 
inspection of immobiline gels few very faint extra lines not explained by variation in glycan 
structure can be seen, but if shown to be related to deamidation this will represent a very small 
proportion. Nonenzymatic glycosylation of plasma proteins which is most widely known from 
haemoglobin ( HbAlc ), but is non discriminative and likewise affects all other circulating 
proteins and matrix proteins. N-terminal Valines can react with glucose forming a Schiff base 
resulting in a-amino glycosylation. Additional E-amino glycosylation of intra-chain Lysines has 
also been registered in haemoglobin, collagen, low density lipoprotein and serum albumin 101 . 
Our carbohydrate analyses are consistent with similar nonenzymatic glycosylation in transferrin 
(table 4 ), but again this will probably constitute only a very small amount, particularly in view 
of the in this context relatively short serum half life of transferrin and slow rate of formation of 
these products. Additional nonenzymatic posttranslational modifications both from endogenous 
( urea, acetaldehyde, pyridoxal phosphate ) and exogenous sources ( acetaminophen, aspirin, 
alky lating agents ) have been described by protein chemists. These are not important in this 
context, but for a review the reader is referred to 101 • 
At least in chickens, the so called nerve derived transferrin appears to be a separate species of 
serum transferrin. This transferrin can be distinguished from serum transferrin by monoclonal 
antibodies102. As judged from the source of the monoclonal antibodies used in this study, the 
structural difference appears to involve an embryonic epitope not expressed in liver-derived 
transferrin. 
Lum et alw3 have isolated a 62000 Dalton transferrin from activated helper-inducer T4-
lymphocytes ( and not inactivated T4 or other T and B lymphocyte subsets ) that constituted 
more than 60 % of immunoprecipitable transferrin in those cells. Absence of carbohydrates 
cannot explain the weight difference, therefore other structural determinants are certainly 
involved. Further structural definition of this substance would be interesting since this 
transferrin has been implicated in the autocrine pathways involved in control of lymphocyte 
proliferation. 
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Chapter 4. 
Transferrin functions 
Transferrin in iron metabolism 
Iron uptake by transferrin 
Cellular transferrin and iron uptake 
Differential occupation of iron binding sites 
Transferrin as Growth factor. 
Transferrin in microbiology 
Management of physiologic iron toxicity 
The discovery of transferrin followed from the work on the bacteriostatic effect of serum. 
Nevertheless, in many books and scientific articles the function of transferrin is described as 
restricted to acting as an inert vehicle for the transport of ferric ions through the body, which is 
an incorrect simplification. Currently the physiological functions of transferrin can be listed as 
follows: 
I. Transport of ferric ions through diverse body fluids. 
2. Stimulation of growth and differentiation. 
3. Non-immunological defence: bacteriostasis and antineoplastic activity. 
4. Protection against toxic effect of metals including iron. 
Transferrin in iron metabolism 
Early studies on systemic iron metabolism 104 have shown that erythropoiesis is the most 
important determinant for the rate of plasma iron turnover. Pregnancy can also pose 
considerable demands on the body, considering that an amount of iron equal to 20-25% of the 
maternal iron stores is delivered to the growing foetus mainly during the last trimester105 
(figure 9 and figure 20 ). 
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Figure 9. Iron fluxes in man. 
The body iron status is regulated at the level of iron uptake rather than at the level of iron 
excretion. A close relation between the rate of mucosal iron uptake and the rate of erythropoi-
esis106 and with the rate of transplacental iron transfer107"109 has been described. The proposition 
that transferrin is the only factor connecting intestine and target cells is questionable. Moreover, 
transferrin is probably not primarily involved in the transport of iron from intestinal cells to the 
circulation. Iron absorption sufficient to be accompanied by high liver iron stores despite 
hypotransferrinernia13·29 suggests that transferrin does not play an essential role in the 
absorption of iron from the intestine. Using chronic hypoxia as a model to stimulate 
erythropoiesis in the mouse, Peters and co-workers have shown that the rate of mucosal iron 
absorption could be dissociated easily from overall erythropoietic rates. Changes in intestinal 
iron uptake do not necessarily reflect changes in plasma iron turnover. The biochemical 
mechanism by which the enterocyte responds to various signals remains unknown. The transfer, 
however, of mucosal iron to the body was shown to depend on bone marrow activityl 10 ·111 • The 
same conclusion was reached earlier for the coupling of mucosal iron uptake and placental iron 
transfer in rodents 109·112. 
Transferrin does play an important role in the continuous redistribution of iron between the 
sites of storage and utilisation (figure 9 ). This again is best illustrated in the rare cases of 
atransferrinemia. Undoubtedly transferrin plays an important role as an iron carrier effecting 
transport between liver, bone marrow, spleen and other tissues. In pregnancy iron is transported 
to the syncytiotrophoblast via transferrin and the transferrin receptor. No alternative routes to 
the embryo are known in humans. The role of transferrin in brain iron metabolism is less clear. 
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Transferrin levels are about 200 times lower in cerebrospinal fluid than in serum, but this is 
matched by the lower rate of iron turnover in the brain. Unfortunately no data are available on 
transferrin levels in cerebrospinal fluid of atransferrinemic idividuals. Possibly in these 
individuals at the extrahepatic sites the transferrin gene is translated at for the organ involved 
normal rates, since trace quantities of transferrin are reported to exist in the serum of these 
individuals and extrahepatic transferrin synthesis is also probable because absolute 
atransferrinemia conceivably would lead to such serious disturbances in brain development that 
the embryonal stage would not likely be survived. A similar reasoning can be pursued for the 
production of transferrin by Sertoli cells; likewise it is not known whether this system is 
disturbed in atransferrinemia. 
Iron uptake by transferrin 
In contrast to the abundance of information on iron uptake from transferrin is the scantiness of 
information available on the physiological acquisition of iron by transferrin. 
In general terms, three systems can be implicated. Firstly, iron could be acquired by transferrin 
during intestinal uptake. Secondly, uptake could be possible in the process of recycling of the 
iron released in the physiological turnover of iron-containing enzymes and proteins, especially 
haemoglobin. This proceeds mainly in the spleen and bone marrow, but also in other cells 
belonging to the mononuclear phagocyte system such as the Kupffer cells of the liver. Thirdly, 
iron could be obtained directly from iron stores, principally located in hepatocytes in the form 
of ferritin and hemosiderin. 
A small number of studies aimed at clarifying the iron-release mechanism have been reported. 
In these, transferrin does not appear to play a direct, active role in release of iron from 
hepatocytes 113 or macrophages 114 • This confirms expectations based on logical arguments. Iron-
free transferrin binds weakly to the transferrin receptor, and therefore the passage of iron from 
the cells to transferrin is not expected to depend on interaction of the protein with the cell 
surface receptor. With respect to hepatocytes, the experimental results are difficult to interpret 
since both iron influx and efflux may occur at the same time. Influx has been estimated at 4.4 · 
104 iron atoms I cell/ minute, but this must be read with caution as influx in hepatocytes is not 
saturated with increasing transferrin concentrations and also it increases with lowering oxygen 
concentrations. Efflux data are not available. 
In addition to this, results are complicated by the presence of the asialoglycoprotein receptor 
system in hepatocytes. Both apotransferrin and iron-containing transferrins can be endocytosed 
through the asialoglycoprotein receptor, but in my opinion this system does not play a role of 
quantative importance in normal iron metabolism (tables 11 and 12 ), or even in iron 
metabolism in alcoholics. 
Studies on iron uptake from the intestinal lumen show that somewhere along the line transferrin 
is involved in its transport to the tissues. No decisive information, however, is present on the 
stage at which iron is bound to transferrin. Finch and Huebers postulated a central role for 
transferrin in mucosal uptake of iron. Transferrin secreted in the gut was postulated to bind 
intraluminal iron and to donate it to enterocytes. Transferrin receptors have been demonstrated 
neither on enterocyte microvillous membranes nor on basal membranes. The intraluminal 
transferrin hypothesis must in my view be discounted. The fact that iron absorption is maximal 
in the duodenum implies that the actual mechanism is either exquisitely dependent on 
physicochemical characteristics of iron salts themselves, or the result of specific characteristics 
of duodenual enterocytes, or a combination of these two elements. What happens at the basal 
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side of the cell is also still not revealed. Recently, Sibille et al115 demonstrated that ferritin is 
released from macrophages after phagocytosis of red blood cells. A considerable portion of the 
iron in this ferritin appears to be easily dissociated and shifted to transferrin in culture media. In 
intestinal iron uptake, red blood cell turnover and in transplacental iron transport such a 
mechanism could in principle be operative. Also, as suggested 115·116 ferritin, besides being a 
protein of iron storage, could be an important iron transport protein since circulating ferritin is 
rapidly cleared by the liver and its iron recovered and stored by hepatocytes. 
Cellular transferrin and iron uptake 
Uptake of iron from transferrin has been very extensively investigated. Two main mechanisms 
of uptake have been proposed that have found conclusive or at least very strong experimental 
support: 
l. Receptor mediated endocytosis with pH dependent iron release from transferrin. 
2. ( Reductive ) release of iron from transferrin at the cell surface . 
Mechanisms such as adsorptive endocytosis of transferrin, fluid phase pinocytosis 117, diffusi-
on118 and others have been proposed, but lack substantial experimental support in favour of a 
physiological role in normal adults. A small note in this context: still common to all theories 
designed to explain iron uptake is that neither of them offer an explanation for the 
transplasmalemmal transport or the transcytoplasmic transport of iron to its final cellular 
destinations, but this is not to nullify the achievements in this field described below. 
These two mechanisms exist in various cell lines with different quantitative ~mportance in each. 
While generally accepted to be the mechanism of iron uptake in the red cell lineage and in 
placenta, receptor mediated endocytosis is disputed to be the quantitatively most important 
mode of uptake in hepatocytes and neoplastic cells 119' 120. Transferrin concentrations attained in 
physiological conditions are above those needed to saturate the transferrin receptors. Under 
those conditions isolated rat hepatocytes take up iron from transferrin predominantly located at 
the plasma membrane, receptor mediated endocytosis therefore playing a less important role in 
this cell type with respect to iron uptake. 
Conjecturing on the available knowledge of the diverse mechanisms as described below, 
reductive release at the cell surface probably qualifies as the phylogenetically oldest method of 
iron uptake. A homologous mechanism has been demonstrated in unicellular eucaryotic 
organisms 121 : through the combined action of a plasma membrane ferrireductase and an Fe(II) 
transporter iron uptake is effectuated and regulated in response to environmental demands in 
yeast. Receptor mediated endocytosis developed m multicellular organisms where 
specialisation of tissues requires high efficiency and high speed of uptake. Bone marrow and 
placenta are such examples; the rate of uptake in nucleated bone marrow cells for instance is 
estimated at 800,000 iron atoms per cell per minute, while in liver cells this figure is about 
40,000 iron atoms per cell per minute, and substantially lower figures are found for resting cells 
such as fibroblasts. 
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The receptor mediated endocytotic cycle 
The endocytotic recycling pathway is known from in vitro studies of iron absorption by cell 
cultures. After having been described by Morgan and Appleton in rabbit reticulocytes 122, 
receptor-mediated endocytosis has been studied in a large diversity of cell types. For instance, 
HeLa cells 123, isolated mouse hepatocytes 124, isolated rat hepatocytes 117 , HepG2 cell87 and K562 
cells 125 have been studied. 
A description of the receptor mediated endocytosis of transferrin is given in Figure 10. 
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Figure 10. Processes involved in the intracellular transport of iron. Transferrin will bind to a transferrin-
or alternatively to an asialoglycoprotein receptor on areas of the cell surface specialised for 
uptake by endocytosis. The iron release from vesicles requires acidification of the endosomes. 
An intracellular sorting mechanism directs the iron-triansferrin-receptor complex to proper 
destinations ( I, II and III). After release of iron the transferrin-receptor complex is either 
externalised undegraded (Ill), or degraded in lysosomes (1). Route II is involves resialylation 
of transferrin and/or its receptor and subsequent recycling to the cell surface. In route IV iron 
bound to transferrin activates a transplasmalemmal NADH-oxidase, possibly with the 
concomitant reductive release of iron (II) from transferrin and uptake of iron 
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Cell surface transferrin receptor binds diferric transferrin from the incubation medium, with 
progressively lower affinities for monoferric and apotransferrin [244]. As reported in the 
introduction, the Ka for the binding of 2FeTf is 20-fold higher than that of apo-Tf, whereas the 
two monoferric forms bind with intermediate affinity. This is in agreement with earlier studies 
in vitro as well as in vivo with respect to the iron donating behaviour of both monoferric 
transferrin species81 -83 • Either with or without transferrin bound to it, within seconds after being 
cycled to the cell surface transferrin receptors are concentrated in dimples in the cell surface 
coated on the cytoplasmic side by an electrondense bristle-like sheet, hence named coated 
pits 126· 127 • This sheet was later shown to be composed of clathrin molecules, responsible for 
automated formation of vesicles. At these coated pits receptor molecules randomly ( re-) 
inserted in the plasma membrane are trapped, irrespective of the identity of their ligand, and 
through this clustering of receptors to specialized fragments of the cell surface and consequent 
concentration of ligand molecules substantial enhancement of the efficiency of the connected 
uptake system is achieved. 
Through further invagination of the cell membrane this dimple in the cell surface evolves into a 
rounded intracellular vesicle, initially connected to the surface by a narrow neck (often 
tortuous and can be up to 1000 nm long). After this the clathrin-molecules segragate from its 
cytoplasmic face to return to the cell surface to initiate a new cycle, and the neck is lost. 
Common terms for these vesicles are endosomes or receptosomes (from each coated pit a 
receptosome is formed every 20 seconds; a typical cultured cell is estimated to form up to 3000 
vesicles per minute). At that point the vesicle size has increased through uptake from the 
cytoplasm to a size of about 200 nm. Size also increases as a result of fusion of receptosomes. 
Receptosomes have been shown to move through the cytoplasm. The typical saltatory 
movement and the fact that it can be arrested by colcemid provide evidence that they move 
along the intracellular tracks laid out by microtubules. Another important property of 
receptosomes is the fact that they become acidic. Depending on cell type a pH varying from 
6.4 128 to 5.5 is reported 125·129, but generally it is accepted that in receptosomes involved in iron 
uptake a pH of 5.5 is attained. Receptosomes move towards elements of the Trans Reticular 
Golgi apparatus and fuse with these elements. After approximately four minutes on the 
surface125· 130.! 31 the receptor appears clustered in vesicles and in tubulovesicular structures near 
the plasma membrane128·132"135 . At this stage, soon after internalisation, the transferrin receptor-
ligand complex is segregated from other receptor-ligand complexes that have co-migrated into 
the coated pits. 
With respect to iron metabolism, a triple role for the acidic pH in these compartments is 
thought to exist: 
1. Sorting of receptor ligand complexes. 
2. Dissociation of iron from receptor bound transferrin. 
3. Recycling of transferrin receptor - transferrin complex to the cell surface and subsequent 
dissociation of apotransferrin. 
The first role: Stoorvogel et al. reported 136 that treatment of HepG2 cells with the 
lysosomotropic agent primaquine does not impede transferrin receptor internalisation, but it 
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totally disrupts the sorting of asialo-orosomucoid and transferrin and concluded that an acidic 
environment is a prerequisite for sorting. Turkewitz et al. have provided a chemical basis for 
this observation137 . The first effect of pH-lowering is to induce a reversible conformation-
transition of the transferrin receptor leading to self-association via the ectodomains 137 . Gradual 
reduction of pH upon penetration of the interior of the cell is hypothesised to be sufficient to 
induce clustering behaviour, resulting in differential concentration of membrane proteins. The 
latter results in sorting of unoccupied and occupied receptors and likewise results in the 
segregation of other pH-sensitive receptors 138• Pertinent to this attractive hypothesis is the fact 
that respective conformational transitions of different receptors and subsequent self association 
occurs at different pH-levels. Thus, in this scheme the diverse physicochemical properties of 
the receptor-ligand complexes would allow for the complex process of early endosomal sorting 
without the specific involvement of cytosolic elements. Additionally, protease insensitivity and 
shielding of tyrosine residues could be obtained, as has been reported for the asialoglycoprotein 
receptors 139, a property obviously necessary for receptor recycling to occur. This may not be an 
important feature for transferrin receptors since receptosomes have not been shown to contain 
hydrolases. Also ligands that are transported to the lysosomes do so not directly from 
receptosomes but via separate smaller coated pits of the Trans Reticular Golgi membrane with 
which the receptosomes fuse first. 
The second role of the acidification of early endosomal compartments is to aid in the 
dissociation of iron from transferrin. Again two mechanisms are involved. Because three 
protons are released for each iron bound, and one from the ionization of carbonic acid to form 
bicarbonate, the association constant for the binding of iron depends inversely to the fourth 
power of hydrogen ion activity 140. The strength of binding of iron by transferrin thus falls by 
orders of magnitude upon lowering of the pH to 5.5. The measured rate of spontaneous 
dissociation from isolated transferrin in solution however despite this still takes hours for 
completion and thus fails to account for the observed rate of iron release in vivo. An additional 
mechanism has therefore long been sought and recently been described simultaneously by two 
groups 141 •142 . Apart from binding the transferrin molecule in the pH range achieved in 
endosomes the receptor appears to facilitate iron release through a pH dependent 
conformational change in the molecule. Diferric transferrin in solution will release about 18 % 
of its iron in 3 minutes at pH 5.6. Diferric transferrin bound to its receptor at pH 5.6 is capable 
of releasing over 50 % of its iron at room temperature in 3 minutes. This rate is likely to be 
faster at 37 'C and, in view of general estimates of endocytosis cycle time of 2 - 15 
minutes88.J 27·130·132· 136·143·144 ( for transferrin estimated at 2-3 minutes ) this can account for 
physiological rates of iron release. 
The resulting apotransferrin-transferrin receptor complex is recycled to the cell membrane. In 
this phase the third benefit of lowered pH is involved: the enhancement of binding of apotrans-
ferrin to the transferrin receptor at low pH 145 . This is considered an additional means of 
deflecting the endocytosed transferrin from lysosomal degradation and is certainly essential for 
the quick return of processed transferrin to the cell surface. Upon its return to the cell surface 
and subsequent exposure to neutral pH the apotransferrin is rapidly displaced by iron 
containing transferrins to engage in another endocytotic cycle87·88·146 . This cycle has been 
measured to repeat 300 times before degradation of the transferrin receptor147 . Current theories 
on the endocytosis pathway hold that the destination of a receptor and ligand is ultimately 
decided in the Trans Reticular Golgi where small ( 80 nm ) coated pits have been shown to 
exist that concentrate ligands destined for lysosomes. Transferrin and its receptor are capable of 
bypassing these pits and finally make their way into narrow elongated membranous elements 
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( like receptosomes intimately associated with microtubules ) extending from the Golgi to the 
cytoplasmic region near the plasma membrane. By fusion with the outer cell membrane 
transferrin bound to its receptor is exocytosed. 
Quantitatively important or not, most cells do take up iron by means of receptor~mediated 
endocytosis. A close coupling of total transferrin 'binding and iron uptake has been described 
for erythroid cells in their various stages of maturation 143·148-150. The role of factors other than 
total receptor number that might regulate the rate of iron uptake, such as the rate of transferrin 
endo- and exocytosis and the efficiency of iron release inside the cell is less well defined. The 
fact that in many types of cultured cells the close relationship between total receptor number 
and the rate of iron uptake ( V max) appears to break down 146·15 L152 suggests the existence of 
other regulatory principles. 
Using primary cultures of chick embryo breast muscle, Sorokin et al. 153 demonstrated that the 
amount of iron taken up at different stages of differentiation is controlled not solely by the 
difference in receptor numbers, but also by the kinetics of endocytosis, receptor recycling and 
possibly by intra- and extracellular distribution of receptors. A comparable conclusion has been 
drawn by Hradilek and Neuwirt154 from their study of iron uptake by induced- and non-induced 
Friend erythroleukemic cells. The Ymax of iron uptake was shown to increase by 100% after 
five days induction with dimethylsulfoxide. This increase was not accompanied by a 
proportional increase in the number of transferrin receptors. In the induced cells transferrin 
endocytosis and release proceeded at identical rates. Transferrin release in the uninduced cells 
was slower and a substantial part of internalised radioiron was released. The data suggest 
differential efficiency of iron release from internalised transferrin and changes in cellular 
transferrin kinetics to be additional factors involved in determining the rate of iron uptake in 
developing erythroid cells. 
Iron uptake from transferrin located at the cell membrane. 
Iron release at the cell surface has definitely been established as the second important mode of 
uptake119·124. The major part of iron accumulated by the isolated hepatocyte can not be 
accounted for by receptor-mediated endocytosis of transferrin. A number of features of iron 
uptake by hepatocytes are not compatible with the receptor mediated endocytosis. Hepatocyte 
iron uptake does not saturate with increasing transferrin concentration, is increased by low 
oxygen concentration, is not significantly inhibited by weak bases or ionopbores and can be 
inhibited by strong Fe(ll) chelators impermeable to cell membranes. Clearly distinguishable 
from the receptor mediated endocytosis pathway, the mechanisms involved have nevertheless 
remained obscure. 
A new element has been added to this discussion by two groups that have demonstrated a 
transferrin receptor-associated transplasmalemma NADH oxidase activity in both isolated rat 
hepatocytes and HeLa cells 155. 157 In the presence of strong cell impermeable Fe(II) chelators 
such as bathophenantroline or ferrozine, extracellular binding of diferric transferrin to trans-
ferrin receptor of rat hepatocytes is followed by reduction of ferric ions to the ferrous state at 
the cost of intracellular conversion of NADH to NAD+. This is accompanied by 
transrnernbranous electron fluxes and concomitant transport of protons via a Na+J H+ 
antiporter. The Fe(II) released from transferrin in this reaction is envisioned under 
physiological circumstances to be transported across the plasma membrane to its intracellular 
destinations (Figure 10 ). 
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Again an important, dual role has been ascribed to the proton flux. Firstly it would aid in the 
labilization of the ferric iron and secondly it would reduce the redox potential of the Fe(Ill) 
bound to the transferrin. The latter is essential in order not to exceed the thermodynamic 
driving force as provided by the NADH oxidation. On theoretical grounds it has been argued 
that the overall equilibrium constant in the experimental set up is shifted towards the formation 
of the iron chelator complex due to the unphysiologically strong chelating effect of 
bathophenantroline, so that transfer of iron from diferric transferrin can not be taken as 
evidence of reductive mobilization of iron from transferrin at the cell surface158 . 
Although in their calculation the authors used an Eo value of -0.528 V while -0.310 V has been 
reported to be the correct figure2, the point they make is valid in that physiological 
concentrations of all substances involved in the overall reaction need be taken into account. 
The problem then is that it is not known which substance functions as the physiological Fe(II) 
chelator. Assuming that -0.310 Vis the correct value for E0, and incorporating the fact that free 
Fe(II) concentrations are naturally kept very low in oxygenated cytosol, an Fe(II)-chelator of 
considerably less strength would suffice to shift the reaction towards reduction of transferrin 
bound iron. As the authors indicated themselves, another variable in the equation, i.e. the 
hydrogen ion, may in vivo be more favourable to the overall reaction as the pH close to the 
hepatocyte's exterior surface is in all probability lower than the pH in the bulk medium due to 
the constant extrusion of hydrogen ions by the hepatocyte156• 
At this moment the stoichiometry of the NADH reductase-reaction in hepatocytes is still 
uncertain. For instance, it has not been proven that it is actually the iron which is reduced at the 
cell surface or even whether it is taken up by the hepatocyte through this mechanism. It can be 
hypothesised that the iron released is immediately oxidised in the surrounding oxygenated body 
fluid and captured by circulating ( apo- or mono-) transferrin and a redistribution of iron 
between circulating transferrin molecules. This appears unlikely since one of the functions of 
the iron binding proteins is the prevention of presence of free ionized iron in aqueous 
oxygenated solution. In particular in close proximity to the cell surface by catalyzing the chain 
of reactions leading to lipid peroxidation serious cell damage would ensue. Alternatively, 
transferrin Fe(II) species could react with ceruloplasmin before liberation of the ferrous iron 
atoms occurs, thus preventing lipid peroxidation, linking the long known ferroxidase effect of 
ceruloplasmin 159 to transferrin metabolism. Another possibility is that transferrin in conjunction 
with its receptor through one of its epitopes could activate this transpl'asmalemrna 
oxidoreductase, employing an alternative extracellular substrate. Either way the net effect of the 
reaction would be an alkalisation of the intracellular medium In this view the system acts as a 
regulator of cell function irrespective of iron donation, a view that provides a biochemical basis 
to the growth stimulating properties of transferrin ( see paragraph on early effects related to 
growth stimulation in this chapter). 
Efforts are currently directed at describing this hitherto cryptic transplasmalemmal diferric 
transferrin NADH reductase. At this moment it is not established whether the above described 
reductive release of iron at the liver cell surface truly describes the quantitatively most 
important mode of iron uptake in the liver. On the other hand, general agreement does exist on 
the fact that isolated rat liver plasma membranes are capable of reducing ferricyanide and 
exhibit diferric transferrin stimulated NADH oxidase activity ( reference158 , own observations). 
Interestingly, the distribution of this transplasmalemmal NADH oxidase is tissue specific. In 
contrast to liver cells Hela cells and melanocytes, the reticulocyte displays little NADH oxidase 
activity 119 . As the latter is almost exclusively dependent upon receptor mediated endocytosis of 
transferrin for iron uptake, it is highly unlikely that the NADH oxidase plays a role in 
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mobilization of the ferric ions from transferrin in endosomes to the cytoplasm. 
Additional modes of transferrin and iron uptake 
A mode of uptake similar to the transferrin receptor mediated endocytosis is followed when 
transferrin is taken up through the asialoglycoprotein receptor. Following internalisation, 
processing is different though. In early endosomal particles, possibly the tubulovesicular 
network identified as the Trans Reticular Golgi, divergence of transferrin-receptor bound and 
asialoglycoprotein-receptor bound transferrin occurs 136 . The latter is routed towards lysosomal 
compartments, resulting in degradation of the transferrin molecule and recycling of the 
asialogycoprotein receptor to the plasma membrane. 
A third mode of intracellular transport of both transferrin and its receptor has been 
reported 16(u 61 . In this mode, desialylated transferrins and desialylated transferrin receptors are 
returned to the cell surface at a much slower rate but are resialylated, suggesting some sort of 
repair mechanism. It is presently not clear which receptor or mechanism is responsible for this 
diversion of the transferrin molecule to the deeper regions of the Golgi complex. It may 
function as a means of restoring functional integrity of these proteins, but plays no role of 
quantitaive importance in iron uptake. 
Foetal liver cells diplay an unusual high rate of iron uptake not comparable to its adult 
counterpart both in rate and in basic mechanism of uptake. For these cells it has been 
characterised as a nonsaturable, transferrin concentration dependent, adsorptive endocytosis-
mode of uptake162. 
Differential occupation of iron binding sites 
As discussed in the introduction, the physicochemical properties of theN- and C-terminal iron 
binding sites are not equal in terms of iron binding. Under conditions prevailing in the 
circulation the effective affinity constants of both binding sites amount to 1 and 6 x I 022 M-1 
respectively42 . Since its first description this difference and its physiological relevance have 
been a widely acclaimed matter of conjecture and debate. 
In 1967, Fletcher and Huehns postulated that the N- and C-sites might play specific roles in 
internal iron exchange. The C- terminal site was hypothesized to be involved in removal of iron 
absorbed by the intestine and in delivery of this iron to bone marrow and trophoblast; the N-
terminal site was assumed to deliver iron preferentially to the iron storing hepatocytes. In vitro 
and in vivo the iron donating properties of FeNTf and TfFec did not differ however8L82, so it is 
now generally accepted that this hypothesis cannot be maintained. 
The in vivo occupancy of N- and C-terminal binding sites is also a matter of debate. There are 
several reports about the ratio of FeNTf over TfFec. Zak and Aisen77, and van Eijk et al.90·163 
reported predominance of FeN Tf over T!Fec in sera of healthy donors. Other groups presented 
contradictory data for peripheral plasma4 L8iufi4 and for supernatants of cultured cells 165 . The 
non-random distribution of iron among the two binding sites is disputed for both healthy 
individuals84 and patients with haematological disorders85 . Serum taken from different vascular 
compartments has been compared with respect to the relative amounts of apo-, monoN-, mono 
C-, and diferric Tf. The patterns describing the relative amounts of these four transferrin 
subspecies did not differ significantly between the different compartments80 . Under 
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physiological conditions the different species of Tf apparently do not serve specific functions in 
directing the flux of iron. The non-random distribution of FeNTf and FecTf has remained 
unexplained. 
A different light on the matter comes from two observations. Firstly and central to the 
hypothesis, pH dependent, receptor induced switch in binding site cooperativity has recently 
been described 166.Through this modulation of the kinetics of iron release from transferrin, the 
transferrin receptor plays a key role in the release of iron from transferrin in endosomes. 
Diferric transferrin bound to its receptor will at the pH prevailing in endosomes release about 
50 % of its iron in the time required for a full cycle of receptor mediated endocytosis to occur. 
This implies that a considerable proportion of internalised transferrin will return to the cell 
surface in its monoferric state. Saturating conditions exist for most cells with respect to the 
concentration of diferric transferrin in relation to the receptor affinity constant Therefore the 
monoferric transferrin with the lower affinity for the receptor will be displaced by diferric 
transferrin soon after the transferrin receptor complex has returned to the cell surface. Why then 
do we still find diferric transferrins in blood ? Probably because the time for such exchange to 
occur is short. At an estimated density of 1000 coated pits per cell together occupying I % of 
the cell surface, based on the lateral diffusion rate of the EGF receptor it has been calculated 
that a recycled receptor will meet another coated pit and engage in a new endocytotic cycle 
within seconds 167 . Presumably this time is short enough for most monoferric transferrins to 
escape exchange and upon descending the next coated pit proceed to delivery of the second 
iron atom. Nevertheless some monoferric transferrins will be exchanged. At this point the 
receptor induced switch in site lability described by Bali and Aisen is interesting. Apart from 
opening the binding cleft in the C-terminal domain, conformational changes induced by the 
receptor also influence the N-terminal lobe to such an- extent that in doubly occupied 
transferrins release from the N-terminal site is slowed. At pH 5.6 the overall effect of binding 
of diferric transferrin to its receptor is stabilisation of iron in the otherwise reactive N-terminal 
site and labilisation of iron in the relatively stable C-terminal site. Whereas in circulating 
transferrin release is fastest from theN-terminal site, transferrin bound to its receptor at pH 5.6 
thus preferably releases its iron from the C-terminal site. Thus, monoferric transferrins released 
from cells will preferably be FeN Tf and considering that the major share of diferric transferrin 
is metabolised in the bone marrow this may explain the predominance of FeN Tf over FecTf in 
peripheral blood. 
A simple test of this proposition involved the isoelectric focussing of bone marrow plasma as 
most of the transferrin turnover via receptor mediated endocytosis occurs in the erythroid cell 
lineage. Consistent with the former line of thought an increased amount of FeNTf in bone 
marrow plasma compared to the amount of FeN Tf in peripheral blood plasma was found by us. 
Returning to the Fletcher-Huehns hypothesis described above, a contrasting view emerges: the 
different species of Tf apparently do not serve to direct the flux of iron between organs, but the 
amounts relative to each other reflect the fluxes of iron to these organs. FeNTf is more or less 
produced locally by bone marrow and other cells actively engaging transferrin in receptor 
mediated endocytosis. This is probably counterbalanced by iron release from stores and organs 
involved in the recycling of iron from erythrocyte turnover as this will at physiological pH 
preferably bind to the site in the C-terminai lobe of transferrin. The physiological benefit of 
favouring the acid stable site over the acid labile site as a source for cellular iron needs has 
been questioned by the authors who described the phenomenon of site cooperativity switch. It 
may be that in effect it preserves the transferrin site that at physiological pH most avidly binds 
iron, thus chelating iron at sites of uptake and recycling most efficiently. 
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Transferrin as Growth factor. 
Serum has a growth promoting effect on cultured cells. Biochemically, a number of serum 
constituents have been shown to be involved in this growth stimulus. For instance insulin, 
insulin-like growth factor, interleukin, platelet derived growth factor, epidermal growth factor 
and serum transferrin have been shown to be independent, effective growth promoting agents. 
For all polypeptide growth factors including transferrin, binding to specific plasma membrane 
receptors is an obligatory step in growth stimulation. This has been shown for transferrin by 
Trowbridge and Omary168 . 
The transferrin receptor is present on the surface of proliferative normal cells, and on benign 
and malignant neoplastic cells169 . The terminally differentiated cell has been shown to exhibit 
little or no significant specific binding sites for transferrin 150·170· 171 • This is particularly clear in 
the erythroid cell lineage where the receptor number increases between the early and 
intermediate normoblast stages, and subsequently the number decreases and finally disappears 
at the stage of the mature erythrocyte. Since there is a high correlation between the proliferative 
state and the level of transferrin receptor expression, the question has arisen whether or not a 
functional relationship between these two exists and what role can be attributed to transferrin in 
this system. Traditionally, the growth stimulating effect of transferrin has been ascribed to its 
function as an iron vehicle. The enzyme ribonucleotide reductase, a key enzyme in DNA 
synthesis, requires iron as a cofactor, rendering it an iron dependent step in cellular 
proliferation. However, new data have become available showing that this is too limited a view 
on the role of transferin in stimulation of cellular proliferation. 
In this context it is useful to differentiate between early and late growth promoting effects of 
transferrin. The neuro- and myotrophic role of transferrin will be dealt with separately, since 
this involves a continuous stimulation of terminally differentiated cells and, in contrast to the 
early and late effects, as such is not implicated in support of cell division. It might be termed 
the anti-senescent effect of transferrin. 
Transferrin as a mitogenic agent 
The question whether transferrin as such has growth promoting properties has long been a 
matter of debate. Differentiating early and late effects is rewarding. Based on the reported 
results one may conclude that membranous and intracellular changes are initiated as an early 
effect, due to a direct transferrin - transferrin-receptor interaction possibly based on an 
electrochemical effect on the cell. These changes could be regarded as the minimal 
requirements necessary for late effects to occur, effects that appear to be basically related to 
iron supply. In a sense these mechanisms function as a positive feedback loop~ a self 
perpetuating automitogenic stimulus. Therefore additional requirements set by other growth 
factors or intrinsic factors ( for instance defined by neoplastic degeneration ) are undoubtedly 
present when transferrin is acting as a growth stimulating agent. Nevertheless, systems in which 
these demands are met can provide information on the physiological role of transferrin in 
growth control. Certainly in its early effects this role goes beyond the level of essential nutrient 
supplier. 
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Early effects. 
The binding of growth factors to the specific plasma membrane receptors promotes generation 
of early signals in membrane and cytosol. Within a minute, the mitogenic signal is propagated 
into the nucleus. A variety of biochemical changes is induced, eventually culminating in 
mitogenesis. Addition of growth factors (or serum) to responsive cells causes changes within a 
few minutes in the activity of a variety of electrolyte and non-electrolyte transport systems, in 
intracellular alkalisation, and in membrane ruffling and cell shape172- 177 • For a review see 
Rozengurth178 . 
The rearrangement of transferrin receptors (TfR), resulting in increased TfR numbers at the cell 
surface at the cost of the intracellular TfR pool, has also been recognised as an early growth 
factor-induced event179·180• For instance, addition of either insulin, insulin-like growth factor, 
interleukin, or platelet derived growth factor to HeLa cells kept in serum-free medium, induced 
a rapid ( t 112 = 3 min ) and concentration-dependent increase in surface TfR number. This 
response was calcium-dependent but unaffected by the presence of Tf, demonstrating that at 
least in HeLa cells TtR distribution is ligand-independent181 • The influence of growth factors on 
TfR distribution cannot be demonstrated in all cell types. Thus Ward and Kaplan speculated 
that only cells that have a substantial quantity of TfR's in intracellular pools may respond to 
mitogen stimulation with redistribution ofTfR 's along with other proteins. 
The physiological relevance of this early serum-dependent rearrangement of TfR 's is not clear. 
Iron being required for the activity of ribonucleotide reductase, a key enzyme in DNA 
synthesis 182, this would appear to be an early target in stimulating cell division. The initiation of 
DNA synthesis is, however, a late event, occurring 10 to 15 hours after addition of the 
mitogens. Therefore the early enhancement of the cellular capacity for transferrin-mediated iron 
uptake can hardly be causally connected with DNA synthesis. 
The hypothesis proposed by Sun et al. 1s3, explaining the growth promoting effect of transferrin 
should be considered in relation to this discrepancy. Insulin-induced increased exposure of 
transferrin receptors at the cell surface is thought to cause an increase in the activity of a plasma 
membrane and transferrin receptor associated electron transfer system; the NADH-diferric 
transferrin reductase. Reduction of transferrin bound iron is accompanied by proton release 
with an H+fe- ratio of over 50. This has been demonstrated for Hela cells 1s3 and rat 
hepatocytes 119 . H+ generated in this reaction by oxidation of NADH and either simultaneous 
reduction of ferric ions presented by transferrin (or, as discussed in the section on reductive 
release of iron from transferrin, another cryptic substrate ) has been shown to exchange with 
external Na+ through tightly coupled Na+/H+ anti porters. Stimulation of this transmembrane 
redox system is therefore postulated to result in alkalinization of the cytoplasm 183 • On the other 
hand alkalinization is related to mitogenic action of growth factors 172• 173 , which thus ties diferric 
transferrin to early growth promotion. Since not all cells respond similarly to mitogenic 
stimulation with respect to transferrin receptor redistribution, this early rearrangement cannot 
be considered as a necessary event in mitogenesis. In principle and at the least, the chain of 
reactions as proposed by Sun et al. could potentiate the growth- promoting stimulus of the 
mitogen in special cell types. Furthermore it allows for the lack of receptor redistribution 
accompanying an early growth stimulating effect of transferrin in some cell types. 
Besides intracellular alkalinization and mobilisation of calcium ions, changes such as turnover 
of phosphatidyl cholines, alterations in the ratios of cyclic nucleotides or redox state of 
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nucleotides, as well as maintaining redox components in the plasma membrane in the oxidised 
state' 84·185 have been implicated in the control of growth. All of these effects can be directly or 
indirectly related to the existence of external oxidants acting upon a transmembranous redox 
system. Artificial electron acceptors, ferric or non ferric type, should be capable of stimulating 
growth via the transplasma membrane redox system. Studies by Ellem and Kay 185 show that 
external ferricyanide can stimulate growth of melanoma cells. Ferric sulphate stimulates growth 
of 3T3 cells 186 and impermeable indigosulphonates stimulate cell division in sea urchin 
oocytes 187. Non-ferric artificial electron acceptors such as hexamine ruthenium III and 
indigotetrasulphonate stimulate growth in Hela cells188·1H9• In fact it has been claimed that all 
external oxidants with redox potentials above -125 mV can stimulate growth188 . That 
modulation of this activity operates as an important principle in development and 
differentiation has been recognized and elaborated in several zoological investigations. The 
development of the vegetative pole of sea urchin oocytes can be stimulated by lithium salts at 
the cost of the development of the animal pole. The reverse can be established with 
isothiocyanate. Similar antagonistic actions have been shown operational in the development of 
eyes and brain in squids and in the regional differentiation of neuroectoderm of vertebrates 190. 
In this view, transferrin is not indispensable in culture media, but is simply one of the 
physiological substrates in an indispensable cellular mechanism. 
Late effects. 
As mentioned, transferrin stimulates cell growth and division by binding to specific 
proliferation-related surface receptors 168. For this reason, the pathophysiological behaviour of 
these specific transferrin receptors must be considered simultaneously. 
Generally, proliferative cells in the early S-phase have increased TfR numbers, whereas the TfR 
in silent cells is nearly absent. A number of exceptions to this empirical rule is known. One of 
them is the villous cytotrophoblast. This particular cell type has been shown to be proliferative 
in early pregnancy and to a lesser extent in the term placenta, despite the absence of surface 
transferrin receptors in situ 191-193. After fusion and I or differentiation to syncytiotrophoblast the 
transferrin receptor (again) comes to full expression, a process which can be studied in in vitro 
cell culture systems256. The presence of the transferrin receptor on the terminally differentiated 
syncytiotrophoblast reflects the transfer function of this materna!-foetal barrier layer. Another 
exception is formed by the terminally differentiated myotube in vitro. This cell type also 
continues to express a high number of transferrin receptors per unit DNA153 . This may reflect a 
continued iron requirement, as suggested by studies of Ozawa and Higawaza194. They 
demonstrated that myotubes require more iron than presumptive myoblasts probably because of 
myoglobin production. A third example is the mammary gland during gland development. The 
work of Schulman et aL 195 demonstrated that growth of the normal -murine- mammary gland 
occurs mainly in mammary epithelial cells and is associated with a clear increase in TfR's. As 
shown by Drewinko et al. 196 for cultured human colon cancer cells, also malignant cells do not 
necessarily downregulate their TfR number when quiescent. Apparently the expression of the 
TtR does not only depend on and reflect the proliferative state, but also depends on the cell's 
specific developmental pathway. 
TtR expression is critical for the G1-S phase transition in malignant as well as in normal T-
cells197. In tissue cultures of both norma] and malignant cells it has frequently been 
demonstrated that in the early S-phase both the rate of DNA-synthesis and TfR expression at 
the cell surface as well as in the whole cell are high as compared to the confluent state of the 
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cell culture198-200. In T-lymphocytes, transferrin receptor expression is tightly coupled to prior 
expression of the specific growth factor interleukin-2. In the normal resting T-cell the transfer-
rin receptor gene is transcriptionally virtually silent, but is activated by mitogenic agents201 . 
This response to growth factor stimulation must be distinguished from the before-mentioned 
early effect; the redistribution of pre-existing TfR's in favour of the cell surface. 
There is little doubt that the enhanced expression of the TfR is related to the late growth-
promoting effect of transferrin. The question remains whether transferrin as such, or the iron 
bound to transferrin, is the active agent. In rat thyroid follicular cells (FRTL5 cells)the growth 
promoting effect of transferrin, as measured by 3H-thymidine incorporation, was mainly 
confined to cAMP- dependent mitogenic pathways activated by thyroid stimulating hormone 
and dibutyryl cAMP'"'. Transferrin had no apparent effect on cAMP-independent stimulation 
of DNA synthesis induced by insulin and IGF-1. Desferrioxamine, a potent intracellular iron 
chelator, could easily abolish the stimulatory effect of the cAMP-dependent mitogens, 
suggesting that in this reaction chain iron was the effective agent, and not transferrin or 
transferrin-bound iron. Stimulation by the cAMP-independent mitogens was much more 
resistant to desferrioxamine treatment200. How exactly iron, transferrin, cAMP, ribonucleotide 
reductase and transferrin receptor synthesis are causally connected is unknown. 
The conclusion that iron is the effective stimulatory agent is strengthened by other 
observations. Cell lines like K-562, HL 60 and KG-I have been grown for many years in 
transferrin-free media containing ferrosulphate202 . Other evidence comes from studies with the 
monoclonal antibody 42/6 raised against the transferrin receptor, which in contrast to the 
monoclonal antibodies OKT9 and B3/25 inhibits transferrin binding in a competitive manner. 
Growth of KG-I, K 562, SV-cells and transformed 3T3-cells was inhibited by monoclonal 
42/6, and addition of soluble ferric nitriloacetate reversed this inhibition203 . However, these 
observations cannot be generalised. Growth of CCRF-CEM cells was not re-established with 
iron supplementation203 . The same group reported earlier that certain monoclonal antibodies 
against the transferrin receptor inhibit growth of granulocyte-macrophage-colony forming unit-
cells, and that this inhibition could not be reversed by iron204. A comparable observation was 
made by Trowbridge and Lopes205, with a tumour cell line in which the inhibitory effect of the 
monoclonal 42/6 on cell growth could not be overcome by iron salts. Moreover the antibodies 
42/6, B3/25, and 43/3 inhibit myeloid cell growth whereas they stimulate iron uptake''"·"J6. One 
must realise, however, that in these experiments total effects are in fact measured. Whether 
proliferation did not occur due to the lack of the so called early effects, or due to the absence of 
late effects has not been substantiated. 
Neuro- ami myotrophic activity 
It is a long-standing clinical observation that denervation of voluntary muscles inevitably leads 
to atrophy of the muscles involved. Passive exercise, frequent direct electrical stimulation of 
muscles and other physiotherapeutic measures have no positive effect on the atrophy. The 
changes induced are reversible though, as evidenced by the gradual recovery after renervation 
of these muscles. Thus a nerve-derived myotrophic factor, excreted and transferred to the 
muscle at the motor end plates, has been postulated. 
Initially, embryo extract was shown to be capable of supporting myogenic development in 
tissue culture. Various other preparations were shown to contain a factor that is capable of 
replacing embryo extract. Active components were isolated and given several names such as 
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Sciatin and nerve derived myotrophic factor. The active substance in these various preparations 
has now been shown to be identical to transferrin 194·207-209 . Not only is the presence of transferrin 
essential for myotube development, it has also been shown to be essential for the maintenance 
of the differentiated state of striated muscle tissue by the nerve210• The fact that the terminally-
differentiated myotube in vitro continues to express transferrin receptors 153 may not only reflect 
a continued iron requirement194, but also a developmentally regulated condition necessary for 
the myotrophic factor to be effective. 
It is not yet clear whether Tf required for myogenesis and for the maintenance of the 
differentiated state of muscle210 arrives from the nerve itsel:P0·210"211 • Ample amounts of 
transferrin could be provided from the circulation, suggesting the possibility that the transferrin 
required is directly routed to its final destination on the cell surface. Again two functions of 
transferrin must be distinguished here; its role in iron donation necessary for myoglobin 
turnover and the myotrophic role. In addition to this, the nerve-derived transferrin has been 
shown to be structurally different from the circulating transferrins 102 • Therefore it is unlikely 
that circulating transferrin is directly involved. On the basis of currently available data it is 
most likely that a specific transferrin is produced locally either by the motor neurone itself or 
by the Schwann cells. In the latter case, transferrin could be donated to the efferent fibre and 
routed to the final destination. A homologous situation seems to exist in the central nervous 
system where the oligodendrocytes provide the cytoarchitectual support and define the 
biochemical microenvironment of neurocytes. Oligodendrocytes have been reported to 
synthesise and store transferrin21 1• Oligodendrocytes of newborn rat brain have been shown to 
be transferrin-independent in culture21 and can even be selected for in cell culture by elimi-
nating transferrin from the incubation medium. Thus oligodendrocytes could possibly deliver 
Tf to developing neurones and astrocytes. Suggestive in this context are the observations of Hill 
and co-workers212 that iron- accumulating areas of the brain are efferent to areas of high 
transferrin receptor density, at least implying neuronal iron transport. Based on these observa-
tions and the apparently developmentally regulated dependence of post-mitotic neuroblasts on 
transferrin in culture213 a neurotrophic role has been ascribed to transferrin. It has been reported 
that nerve derived transferrin is slightly different from the serum protein 102 in all probability 
due to posttranslational modification, and elucidation of the structure of this particular 
transferrin will be of interest. 
Transferrin in microbiology 
Early descriptions of cases of so-called atransferrinemia have pointed at a role for transferrin in 
antimicrobial defence 13·29. Besides severe hypochromic anaemia, repeated infections by 
predominantly Gram-negative bacteria dominate the clinical picture. Furthermore, transferrin 
appears to be beneficial in gramnegative sepsis214• Another member of the transferrin group, 
lactoferrin, also displays antimicrobial activity against Gram-negative bacteria, but the 
mechanism of action has not been defined. Initially this antimicrobial effect of (iron-free) 
transferrin was explained by the competition of transferrin and bacterial siderophores for iron, 
thus depriving bacteria, but also fungi and protozoa, from this essential nutrient. As an element 
of the acute phase response the concomitant increase in concentration of lactoferrin at sites of 
inflammation further enhances the production of an iron-deficient environment that limits 
bacterial growth. 
Endotoxin-binding capacity of human transferrin and Gc-globulin has been demonstrated in a 
qualitative manner215 . This binding of endotoxins occurs under more physiological conditions 
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than described for the high density lipoproteins, to which thus far the role of physiological 
endotoxin-scavengers had been ascribed. The pyrogenicity and mitogenicity of a number of 
different endotoxins are inversely related to their transferrin binding capacities216 • Binding of a 
wide range of bacterial endotoxins has also been described for lactoferrin. In both lactoferrin 
and transferrin this effect is blocked by saturation with iron. This and observations on the effect 
of synthetic chelators on bacterial cell wall stability have lead to an additional explanation of 
the bacteriostatic potency of both lactoferrin and transferrin. The presence of divalent cations 
within the bacterial membrane appears to be critical in stabilising the strong negative charges of 
the core oligosaccharide chain of the lipopolysaccharides molecules. Binding these membrane-
associated cations, EDTA releases lipopolysaccharides molecules from the outer leaflet and, 
upon replacement by nonpolar phospholipids from the inner leaflet, it sensitises the bacteria to 
the effects of complement and lyzozyme. In a nonphysiological sense antibacterial defence is 
augmented, as the membrane becomes more permeable to hydrophobic antibiotic agents that 
are normally excluded by the hydrophylic lipopolysaccharides-barrier. It is hypothesised that, in 
a manner comparable to the synthetic chelator, lactoferrin and transferrin cause 
lipopolysaccharides release from Gram-negative bacteria and alter the permeability and 
sensitivity of the Gram-negative outer membrane. 
In some Gram-negative bacteria transferrin and lactoferrin fulfil ambivalent roles. Neisseria 
meningitidis and Neisseria gonorrhoea, being Gram-negative organisms, are susceptible to the 
above described attack on membrane integrity. Competition for circulating iron is not operative 
in this case, since neither of these bacteria produces siderophores217 , but host transferrin and 
lactoferrin are utilized for iron uptake. 
Meningococci have been shown to possess a specific receptor for human transferrin with a 
relatively low Kct of 0.7 11m218 The relatively low Kd is sufficient for binding transferrin, since 
in many body fluids transferrin is present in concentrations exceeding 1 J1M. Moreover, 
apotransferrin and saturated Tf compete for the receptor equally well. These two characteristics 
are not surprising when viewed in the context of the fact that, unlike the situation in eucaryotic 
cells, Tf is not internalised after binding to pathogenic Neisseria species. Therefore high 
affinity binding of Tf in favour of apoTf as a means of optimising iron uptake is unnecessary. 
Low affinity binding results in high turnover of Tf at the cell surface. This may allow the 
meningococcus to sort the available Tf and remove Fe from iron saturated Tf molecules. The 
gonococcus also possesses lactoferrin and transferrin receptors that are highly specific for the 
human proteins219 • The fact that both rnenigococci and gonococci do not produce siderophores 
and express lactoferrin and transferrin receptors, suggests that this property may be at least 
partially responsible for conferring the human host specificity of N. gonnorhoea and N. 
meningitidis. 
Another example of an organism that has circumvented this non-specific defence mechanism by 
incorporation of it in its own iron metabolism is the malaria parasite. Like all cells the malaria 
parasite is dependent upon an adequate iron supply for its development. In the human host, in 
its proliferative stage the parasite is present within the red cell lineage. Paradoxically, in this 
potentially iron-rich environment Plasmodium falciparum apparently utilises none of the 
twenty millimolar intraerythrocytic heme for its iron supply although this intra- erythrocytic 
parasite possesses proteases capable of degrading the protein part of haemoglobin. Rather the 
metal is obtained from extra-erythrocytic transferrin220 The fact that mature red blood cells 
have no transferrin receptors seems contradictory. However, evidence has been provided 
indicating that this parasite synthesises its own transferrin receptors that are subsequently 
incorporated into the red cell membrane enabling it to take up iron from transferrin22u 22. 
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Possibly this ability may be a distinguishing feature explaining the fact that Plasmodium ovate 
infection is restricted to reticulocytes: These malaria parasites may not be capable of 
synthesising transferrin receptors. Along the same line the mitigated clinical picture produced 
by Plasmodium ovale compared to the clinical picture of malaria due to infection by 
Plasmodium falciparum may be explained. Severity of the disease is principally related to the 
percentage of red blood cells infected. Although the amount of reticulocytes is increased due 
the haemolytic anaemia induced by the infection, the infectious load attained by Plasmodium 
falciparum in mature red blood cells can never be matched by that of Plasmodium ovate in 
reticulocytes alone. 
Irrespective of the question whether a particular organism is either non-specifically hampered 
in its growth, or specifically dependent upon the presence of iron carrying proteins, both 
lactoferrin and transferrin appear to play a role in the physiological defence against infection. 
This role is even more pronounced in the hypoferremic environment induced by interleukin I in 
the acute phase response. Lactoferrin is probably most important in view of its presence in 
secreta and secretory granules of neutrophil granulocytes. This is further supported by the fact 
that lactoferrin retains its high affinity for iron at the low pH that can exist at sites of inflam-
mation, whereas transferrin bound iron is labilised at a low pH. 
Management of physiologic iron toxicity 
Respiring cells are under the continous stress of free radicals. Free ionized iron is therefore a 
potentially very toxic substance in oxygenated fluids as it will catalyze the formation of 
hydroxyl radicals, initiating the chain of reactions leading to lipid peroxidation and cell 
damage223 . These are constantly being introduced either from exogenous or from endogenous 
sources as a consequence of normal metabolism. The continuous formation of superoxide 
anions and hydrogenperoxide exposes cells to the constant risk of being attacked by hydroxyl 
radicals which can be formed from these two precursors in the presence of transition metals. 
Iron bound to transferrin or lactoferrin has been shown not to catalyze the formation of 
hydroxyl radicals. Therefore, one of the important functions of the iron binding proteins is the 
prevention of presence of free ionized iron in aqueous oxygenated solution. Inhibition of free 
radical formation by endogenous free radical scavengers and enzymatic defense systems in 
conjunction with the binding of free iron by the iron carrying proteins constitute a vital buffer 
against the unabating oxidative stress of aerobic life. 
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Chapter 5. 
Structural characteristics of transferrin microheterogeneity 
Describing microheterogeneity: combination of 
separation by isoelectric focusing with separation on 
the basis of degree of branching. 
Preparative isoelectric focusing in immobilized pH-
gradients. 
Carbohydrate analysis of microheterogeneous forms 
of transferrin 
The following 3 chapters cover the experimental work performed. Part of it has already been 
integrated in the preceding chapters as this would aid in understanding the principles that 
govern the phenomenon of microheterogeneity, which was after all the starting point of these 
studies. 
The choice between various methods of describing microheterogeneity which can be performed 
with precision and reproducibility is very limited when looking for practical methods applicable 
to small quantities of sample. Having reviewed the available techniques isoelectric focusing 
was deemed the most suitable. In performing the work I have taken advantage of the wide 
experience in application of electrophoretic techniques (in particular isoelectric focusing) 
available in our department. Disregarding this practical, local advantage isoelectric focusing is 
still the most convenient method to describe transferrin microheterogeneity. 
Interpretation of the patterns is a related problem: what you see is what you get. Therefore 
carbohydrate analyses were performed to assess the exactitude of assumptions on the structure 
of transferrin fractions isolated by isoelectric focusing. For this purification of transferrin 
subspecies, a protocol for isolation by isoelectric focusing has been developed, and these 
isolated subspecies have also been used in the various tests aimed at discerning a function of 
transferrin that might be modulated by variation in the carbohydrate structure. which was a 
hypothesis developed on the basis of changes observed in the microheterogeneity pattern in a 
number of ( patho-) physiological conditions. An account of results is given in these following 
chapters. In order to optimize legibility of text and tables. materials and methods and standard 
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deviations of measurements are described in detail in appendix A and B. 
Describing microheterogeneity: combination of separation by isoelectric 
focusing with separation on the basis of degree of branching. 
In the context of this chapter microheterogeneity is defined as the structural variation m 
monomeric protein due to variation inN-linked glycan structure. Many methods have become 
available that in one way or another can most often only partially describe this structural 
diversity. In principle exact description of glycan stucture is possible, but in view of the 
relatively large amount of protein need_ed in such analyses, without exception also impractical. 
Fortunately, transferrin is relatively simple with respect to its glycosylation. Most serum 
glycoproteins contain 3 or more N-linked glycans and a number of 0-Jinked glycans. 
Transferrin contains no 0-linked glycans and only 2 N-linked complex type glycans, rendering 
the electrophoretical behaviour relatively simple to describe. By the same token Concanavalin 
A affinity chromatography will yield a limited number adequately separable fractions of almost 
unequivocal definition. (figure II ). 
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Figure 11. Concanavalin A Sepharose chromatography of human serum transferrin. 
Isoelectric focusing in Immobilines is one of the most sensitive methods available to separate 
molecules on the basis of differences in ionizable groups. It makes good use of the fact that the 
net electric charge of proteins in aqueous fluids is pH dependent. Immobilines are used to 
create a fixed pH-gradient in a gel that will itself not be altered by the electric field that is 
applied to it. Proteins added to the gel however will move between cathode and anode for as 
long as they have not reached that position in the gel where the pH is equal to its isoelectric 
point, causing the protein of interest to accumulate at this particular point, or in other words to 
be focused to that position in the gel. 
Previously isoelectric focusing was performed using ampholine-mixtures to create the pH-
gradient. In principle this is a similar technique, but because the ampholines are dissolved in the 
gel rather than fixed to the meshwork of gel fibers, pH gradients are steeper and separation ·of 
transferrin subspecies differing 0.1 pH unit was incomplete. The novelty of the more recently 
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become available Immobiline gels lies in the fixation of the pH-gradient onto the matrix of the 
gel, which allows for much shallower pH-gradients to be created. Hence, accurate and 
reproducible quantification of several transferrin relative to each other became feasible 
(figures 12 & 13 ). 
7 2 
Figure 12. Crossed immuno isoelectric focusing of serum. Numerals indicate the number of sialic acid 
residues per protein molecule. Cathode at right and bottom for first and second phase, 
respectively. 
Initially quantification was performed by a crossed (rocket )immunoelectrophoresis. The area 
under the curves was measured and by division on the sumtotal of surface area of all fractions 
the relative amount of each could be determined. Later after purchasing a laser densitometer we 
were able to quantify the relative amounts by measuring the absorbance in the gel after 
immunofixation and subsequent staining for protein. This gives numerically identical results, 
but is a much less labour-intensive method with even better base line separation and 
reproducibility of results ( figure 13 ). 
Purposely simplifying the picture somewhat ( 4th paragraph chapter 3 ) one can safely assume 
that for diferric transferrin heterogeneity visualised through variation in the isoelectric point is 
in a single individual the reflection of variation in the number of the sialic acid residues per 
molecule. As explained in chapter 3, in complex type glycans the degree of branching of the 
complex type glycans determines this number. Further variation can be present as a result of 
either aberrant or incomplete synthesis or desialylation. To be able to asses the influence of the 
latter two factors an additional analysis was performed on the three transferrin fractions that can 
be separated by degree of branching of glycans by concanavalin A affinity chromatography. 
The endresult is the distinction of 18 transferrin fractions (table 2 ). 
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Table 2. Transferrin microheterogeneity in normal serum as distinguished by degree of 
branching of glycans and by number of sialic acids per molecule (expressed as 
fraction in % ). 
Concanavalin A 
separation 
Sialotransferrins bi-bi-antennary bi-tri-antennary tri-tri-antennary Total 
0 - - -
I - - -
2 2.3 0.2 2.5 
3 7.1 0.2 7.3 
4 65.4 0.8 0.! 66.3 
5 0.7 18.0 0.2 18.9 
6 - I. I. 3.7 4.8 
7 - 0.1 0.1 
8 -
Total 75.5 20.3 4.1 99.9 
Trace quantities of the 0, I and 8 - sialotransferrins are visible on gels but have been 
disregarded in this table. In essence the graphs shows that the 4, 5 en 6 sialotransferrins can 
reliably ( 87.2 out of 90.1 correct) be interpreted as signifying the amount of transferrins 
carrying predicted, exemplary complex type glycans. Therefore, by virtue of its comparatively 
simple carbohydrate structure, we could also use the isoelectric focusing of transferrin as the 
probe through which changes in protein glycosylation in physiological and pathological states 
could be monitored. 
~rv, -~~-----
Figure 13. Top half: densitometric scan of sialotransferrins separated on Immobilines. Bottom half: 
separation in ampholine gel. 
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Preparative isoelectric focusing in immobilized pH-gradients. 
Overloading a gel generally leads to adverse consequences when separating compounds 
electrophoretically. A gel is essentially a volume of water coordinated by crosslinked, tangled 
networks of hydrophilic polymers, which second to the water, is the most abundant element of 
the gel. Small cations and anions are also present in minor amounts. The affinity of the 
polymers prevents the network from collapsing onto itself, and also prevents the water from 
flowing away. Upon loading of the gel with the substance of interest, macromolecules spread in 
the gel, competing for free water molecules. For isoelectric focusing in immobilized pH-
gradients in 5% T gels, the maximumloading capacity has been shown to be fixed at 40 - 45 
mg/ml gel, irrespective of molecular mass and surface charge of proteins investigated224. 
Relatively few free water molecules are available to proteins that have to gain access to the gel. 
Focusing enhances this problem~ having arrived at its pi-position, focused protein accumulates 
and increasingly competes for free water molecules. Focusing powers are indeed so strong that 
concentration of the proteins proceeds to the point where osmotic effects lead to the absorption 
of water from surrounding gel regions. Movement in the Y -axis being limited by isoelectric 
forces,and movement in the X-axis simply being limited due to the fixed size of the gel, this 
osmotic effect leads to expansion in the vertical axis, stretching the gel fibers and cusing local, 
visible swelling of the gel at the various pi-sites at first. 
Figure 14. Preparative isoelectric focusing of diferric transferrin in Immobiline gels. Droplets of 
concentrated micro heterogeneous forms of transferrin have formed on the surrface of the gel 
after prolonged isoelectric focusing. 
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Sooner or later, depending on the tenacity of the gel, the physical capacity of the gel is 
overstretched. Liquid accumulation at the pi-sites proceeds to the point where gel affinity 
forces are defied and fluid escapes from the matrix onto the surface, inevitably containing the 
focused protein at its maximum prevailing concentration. This effect becomes visible in the 
formation of droplets on the surface of the gel. Movement of the droplets will not occur, as 
protein outside its maximal concentration absorbs water from the gel, resulting in loss of the 
osmotic driving force and reentry in the gel, in turn followed by transport to its pi-position. The 
size of the droplets is therefore dependent upon the amount of protein loaded onto the gel. 
Inevitably, due to the overriding of the buffering capacity of the immobilines at and near to the 
pi-positions of the proteins to be separated, the separation of proteins is reduced. In the present 
experimental design the transferrins are separated by distances that tolerate this regional 
blunting of the pH-gradient caused by local high concentration of protein. Nevertheles if left 
uncontrolled merging of fractions would occur and for this reason droplet sizes need to be 
restricted, which can be done by simply removing them before loading additional sample on the 
gel. Another important feature in our approach has also been that we have started out by 
isolating blood from transferrin-C1 donors and thus genetically homogeneous transferrin. Other 
permissive factors are the fact that transferrin is a stable protein at room temperature, well 
soluble in aqueous solutions, not sensitive to anodal oxidation or cathodic reduction and 
resistant to spontaneous and microbial decomposition. 
Equilibrating an immobiline gel with protein quantities by far surpassing the loading capacity 
of the gel while maintaining excellent separation of the subtractions, diferric 
microheterogeneous forms of transferrin can be isolated easily, which is demonstrated most 
persuasive in figure 14. Not evident in this figure is the distinctive orange colour of diferric 
transferrin that is unmistakably present on visual inspection of the droplets on the gel. Recovery 
of the protein was simple and effective with an 88% direct total protein recovery ( table 3 ). 
Table 3. Isolation of microheterogeneous forms from 100 mg human transferrin-C 1 isolated 
from serum by immunoaffinity chromatography. 
Transferrin fraction pi mg recovered 
2 Sialotransferrin 5.7 2.5 
3 Sialotransferrin 5.6 8.2 
4 Sialotransferrin 5.45 62.0 
5 Sialotransferrin 5.3 14.2 
6 S:ialotransferrin 5.2 1.5 
Results were checked by analytic isoelectric focusing of isolated fractions and showed besides 
the desired fraction at the most a trace amount ( < 2 % ) of the first next more acidic transferrin 
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for each sample. 
The transferrins described in table 3 were used for carbohydrate and aminoacid analyses, in the 
incubation experiments on hepatocytes and -in determining the affinity for placental transferrrin 
receptors. The incubation of human bone marrow, the activity of the NADH reductase and iron 
binding constants were assessed employing microheterogeneous forms that were defined even 
more unequivocal as these were separated first on the basis of glycan branching by 
concanavalin A affinity chromatography (figure 25). This resulted in the isolation of bi-bi-
antennary tetrasialotransferrin, bi-tri-antennary pentasialotransferrin and tri-tri-antennary 
hexasialotransferrin. For example, disturbance of results by tri-tri-antennary 
tetrasialotransferrin is not to be expected in these experiments. 
Carbohydrate analysis of microheterogeneous forms of transferrin 
The structure of most of the N-linked glycans of human transferrin has been established by 
techniques such as methylation analysis and 1 H N.MR spectroscopy225·226. In these cases glycans 
are either chemically or enzymatically separated from the protein prior to the carbohydrate 
analysis. Therefore quantification of the relative amounts of the microheterogeneous variants of 
a glycoprotein defined by these techniques cannot be achieved and also fractions occurring in 
very small amounts are likely to be lost because of necessary simplification steps in the inter-
pretation of results. 
Only indirect evidence for the structural composition of the carbohydrate moiety of 
microheterogeneous components is available. The objective of these analyses was to check the 
accuracy of the nomenclature of subtractions, as adopted on the basis of the fact that the 
rnicroheterogeneity pattern can be reduced to one single fraction ( asialotransferrin ) in a 
stepwise fashion by sialidase. 
Transferrin isolated by immunoaffinity chromatography of serum obtained from healthy donors, 
all shown to be homozygous for the C I allele by analytical isoelectric focusing, was used in 
these aminoacid and carbohydrate analyses. Subfractions designated 2 sialo to 6-sialo were 
prepared as described in the paragraphs on preparative isoelectric focusing in immobiline gels. 
Arninoacid analysis of these subtractions revealed no differences between the 
microheterogeneous forms, confirming that fractions isolated differ mainly in carbohydrate 
content. Results of N-acetylglucosamine and neutral carbohydrate determinations are shown in 
table 4. 
The results are consistent with the proposed nomenclature. The stepwise increment in the 
number of galactose and N-acetyl glucosamine residues is in concordance with the degree of 
branching of expected complex type glycans attached to particular subtractions. Integer number 
were not achieved which can not solely be ascribed to impurities in isolated fractions in view of 
observed ratios between carbohydrates. This claim is further substantiated by the additional 
carbohydrate determination on 4 and 5-sialotransferrin that had been purified by concanavalin 
A affinity chromatography before isoelectric focusing. The shift in N-acetylglucosamine and 
galactose in the direction of integer numbers is an indication that a small proportion of protein 
carrying 2 bi-antennary glycans but nevertheless 5 sialic acid residues exists. 
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Table 4. Carbohydrate composition of sialo-variants of human transferrin 
After trifluoroacetic acid hydrolysis of isolated transferrrin subfractions neutral 
carbohydrates were determined in a single run on an adapted Multichrom M 
Analyzer with a 60 em long column filled with Aminex A-6 resin. Data represent 
means of three determinations. Results are expressed as moles aminoacid per mole 
protein. N-acetyl glucosamine has been determined simultaneously with aminoacids. 
Sialic acids were determined according to the spectrophotometric method of 
Horgan227• 
Subfraction Carbohydrate Measured Expected* 
2 Sialotransferrin N-Acetylglucosamine 7.6 8 
Mannose 5.1 6 
Galactose 3.7 4 
Sialic acid 2.1 2 
3 Sialotransferrin N-Acetylglucosamine 8.3 8 
Mannose 5.2 6 
Galactose 3.9 4 
Sialic acid 3.1 3 
4 Sialotransferrin N-Acetylglucosamine 8.2 8 
Mannose 5.6 6 
Galactose 4.1 4 
Sialic acid 3.9 4 
5 Sialotransferrin N-Acetylglucosamine 8.7 9 
Mannose 5.7 6 
Galactose 4.8 5 
Sialic acid 4.8 5 
6 Sialotransferrin N-Acetylglucosamine 9.4 lO 
Mannose 6.0 6 
Galactose 4.7 6 
Sialic acid 5.8 6 
*The expected value is based on the numbers to be found in transferrins carrying completed glycans. Two biantennary 
glycans contain 4 sialic acids, 4 galactose, 6 mannose and 8 N-acetyl glucosamine residues. The combination of a di-
and a tri-antennary glycan will together contain 5 sialic acid, 5 galactose, 6 mannose and 9 N-acetyl- glucosamine 
residues. 
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In all fractions a small amount of glucose and fucose ( 0.2 mol/mol ) was found. The glucose is 
most probably due to nonenzymatic £-amino glycosylation of lysyl residues in the protein and 
this is not related to the N-linked glycosylation. Fucose can be part of N-linked glycans, 
particularly linkage to the N-acetylglucosamine in the common core structure has been 
described, but therefore it has no relation to variation in branching. As an independent variable 
it is of uncertain significance in transferrin. It was found in amounts equivalent to fucosylation 
of one in 10 glycans. Also nonenzymatic linkage to the protein moiety analogous to glucose has 
not been ruled out. 
Table 5. Carbohydrate analysis of transferrin subtractions selected for glycan branching type 
by concanavalin A affinity. 
Subfraction 
Bi-bi-antennary 
4 Sialotransferrin 
Bi-tri-antennary 
5 Sialotransferrin 
Carbohydrate 
N-Acetylglucosamine 
Mannose 
Galactose 
N-Acetylglucosamine 
Mannose 
Galactose 
Measured Expected* 
8.3 8 
6.0 6 
4.1 4 
9.3 9 
6.0 6 
5.0 5 
In conclusion, the assumption that transferrin subspecies that can be separated by isoelectric 
focusing represent proteins that differ only in the structure of N-linked glycans is supported by 
these data and permit interpretation of the pattern in the fashion described above ( page 15 -
21 ). 
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Chapter 6. 
Transferrin microheterogeneity in vivo. 
Microheterogeneity patterns in vivo. 
Identification of factors influencing 
microheterogeneity patterns. 
Regulatory aspects of N-glycosylation and 
protein synthesis. 
Hypothesis on the role and rationale of 
glycosylation changes. 
Different degrees of sialylation and galactosylation of human transferrin in biological fluids 
such as cerebrospinal fluid, amniotic fluid and synovial fluid have been described90·228 . The 
occurrence of a particularly high proportion of asialotransferrin in cerebrospinal fluid has been 
put to use in a clinical setting. Early diagnosis of cerebrospinal fluid leakage, most commonly 
presenting as otorrhea or rinorrhea, can be of vital importance since recurrent meningitis is one 
of the serious complications. Cerebrospinal otorrhea and rhinorrhea are notoriously difficult to 
diagnose, often requiring labour-intensive, costly radiographic procedures that are not without 
risk to the patient. By analysing the microheterogeneity pattern of suspected fluid and 
demonstration of the existence of a pronounced asialotransferrin band, the initial diagnosis 
cerebrospinal fluid leakage can be rnade229 . 
Variation in the microheterogeneity pattern of transferrin can also be found or induced by 
several pathological and physiological conditions. A highly aberrant pattern has been described 
in children suffering from a rare syndrome dominated by neurological abnormalities 230·231 . The 
di- and asialofractions are present in high concentrations, a phenomenon which also occurs in 
the cerebrospinal fluid of these children. Not only transferrin is abberantly glycosylated in this 
condition. Other glycoproteins such as a.1 antitrypsin and ceruloplasmin have been found to be 
glycosylated differrently232·233 . A hitherto not yet exactly defined metabolic error in the early 
steps of protein glycosylation leading to the synthesis of glycoproteins with reduced numbers of 
otherwise normally structured glycans is the basis of this disease, now known ass the 
carbohydrate deficient glycoprotein syndrome. 
More subtle changes are induced in rheumatoid arthritis and idiopathic hemochromatosis. In 
sera from these groups an increased proportion of the highly sialylated transferrins and a 
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decreased proportion of tetra-and desialylated transferrins are found compared with healthy 
controls. 
Microheterogeneity patterns in vivo. 
In the following studies we have for the first time fully described microheterogeneity patterns 
observed in a number of groups of individuals, and quantitated these not only in relative 
amounts but also in actual concentrations of subtractions. The investigated groups are presented 
in table 6. 
Table 6. Investigated groups. 
Designation Group Description n 
c Control males 8 
N Control females 13 
pregnant women, week 8-16 12 
n pregnant women, week 17-26 10 
m pregnant women, week 27-40 18 
AT pregnant women, a terme week 36-40 9 
pp 3 days postpartum 9 
PPM 5 weeks postpartum 7 
0 women on oral contraceptives 7 
Fe Iron deficiency anemia 9 
RA-NA Rheumatoid arthritis, not anemic 6 
RA-Pe Rheumatoid arthritis, iron deficiency 6 
RA-ACD Rheumatoid arthritis, anemia of the chronic diseases 6 
The rationale for choosing this wide range of groups should be clear from the discussion as it 
was hoped that through the respective denominations of ( patho- ) physiologic circumstances 
both information on regulatory aspects of transferrin protein and glycan synthesis and 
information on the role of microheterogeneity in rion metabolism would be obtained. 
In tables 7,8 and 9 results are given ( standard deviations in accompanYing tables in appendix A 
). Groups of patients have been designated as explained in table 6. 
Between males and control females no significant differences existed in diferric transferrin 
spectrum, total and fractional transferrin concentrations. 
Of a number of control male individuals repeated blood samples have been taken. These data 
show that there was very little variation in the spectrum of sialotransferrin variants in the course 
of 3 months (table 12 ). 
-52-
Table 7 Variation of pattern in control male individuals. Microheterogeneity patterns were 
determined in four individuals 3 times in three months. The number of intra-
individual comparisons possible thus amounts to 12 and the maximum inter-
individual comparisons sums up to 54 combinations. 
transferrin sialo - variants ( % ) 
mono di 
Average distribution { n = 4 ) 0.0 2.6 
Maximum inter-individual variation 0.0 !.I 
( n = 4; 54 combinations) 
Maximun intra-individual variation 0.0 0.2 
( n = 4; 12 combinations ) 
Besides confirming the recognized effect of 
pregnancy on total transferrin synthesis, our 
results showed a consistent, progressive 
redirection of synthesis towards highly 
sialylated transferrins in the course of 
pregnancy. This effect became statistically 
significant in the second trimester, and the 
trend appeared to be continued up to the last 
week of pregnancy. Compared to any of the 
other investigated groups pregnancy had the 
most pronounced effect on the 
microheterogeneity pattern. After delivery, 
changes were rapidly reversed. This was 
demonstrable as early as four days after 
delivery and 5 weeks later both 
concentrations and subfraction-pattern had 
virtually normalized ( tables 8 and 9, figure 
15 ). The trisialo-transferrin decreased 
significantly in its percentual representation, 
and the disialotransferrin was maintained at a 
constant level. Women using oral 
contraceptives displayed a similar trend: 
concentration of total transferrin was 
increased and compared with the proportional 
distribution in controls, more of the increase 
was accounted for by the highly sialylated 
variants. Compared to pregnancy it differred 
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Figure15. Transferrin micro-
heterogeneity in first trimester, at 
term and one month after delivery 
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in that at the same level of increment of total transferrin concentration, the change in the 
proportional representation was less marked than in pregnancy. 
Iron deficiency was accompanied by an increased total transferrin concentration, the group 
average being risen by 48.2%. Relative proportions were shifted considerably less towards the 
highly sialylated fractions, reaching statistical significance only for the penta-sialotransferrin. 
Compared to pregnancy total transferrin concentration in iron deficiency was higher, and most 
of the actual increment m concentration was due to increased production of 
tetrasialotransferrin. 
Table 8. Proportional distribution of transferrin subtractions in groups as defined in table 6. 
Group 
M 
c 
ll 
lii 
AT 
pp 
PPM 
Fe 
OAC 
RA-NA 
RA-Fe 
RA-ACD 
Distribution expressed as percentages of total amount. Statistical comparison of 
results with control; p < 0.01 indicated by*. Statistical comparison of results within 
RA groups to RA-ACD; p < 0.01 indicated by# 
mono di tri tetra pent a hex a he pta 
0.0 2.5 7.3 66.3 18.9 4.8 0.1 
0.0 2.3 7.7 67.9 17.7 4.4 0.1 
0.0 2.6 8.5* 64.3* 19.5* 4.9 0.1 
0.0 3.0* 6.7* 58.0* 24.6* 7.1 * 0.6* 
0.0 2.7* 5.8* 56.9* 24.8* 8.6* 1.1* 
0.0 3.0* 5.0* 57.2* 24.8* 8.9* 1.1* 
0.0 2.0 8.3 61.6* 23.0* 7.0* 0.3 
0.0 2.6 6.7 64.5 20.4* 4.7 0.1 
0.1 2.5 6.4 65.5 20.5* 4.7 0.4 
0.0 2.7 6.7 63.1 * 21.1 * 6.3* 0.2 
0.0 2.7# 6.9# 63.1 * 20.9*·# 6.0*-# 0.4# 
0.0 2.4 6.3* 59.9* 23.4* 7.1 * 0.7* 
0.0 2.0 4.0* 60.5* 24.4* 7.9* 1.1 * 
The patients with active rheumatoid arthritis generally had a lowered total transferrin 
concentration. The decrease was less in the subgroup with concomitant iron deficiency, but still 
significantly low compared to healthy controls. The microheterogeneity pattern was again 
changed in favour of the highly sialylated transferrins. This change was least pronounced in the 
nonanemic RA patients and most pronounced in the ACD-group, with the iron deficiency group 
occupying the intermediate position. The synthetic balance was shifted to the extent that in both 
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the iron deficiency and ACD-subgroups the concentrations of penta-, hexa- and 
heptasialotransferrins were not significantly depressed compared to controls, while the total 
transferrin concentration in these groups was diminished by 15.1 %and 38.8% respectively. 
The tetrasialotransferrin was significantly depressed in both proportional representation and in 
concentration in all RA subgroups, and a similar effect is observed for the di-and trisialo-
transferrin. 
Table 9. Concentrations of transferrin subfractions in groups as defined in table 6. Results in 
~mol!l. Statistical comparison of results with control; p < 0.01 indicated by *. 
Statistical comparison of results within RA groups to RA-ACD; p < 0.01 indicated 
by# 
Group di tri tetra penta hex a he pta Total 
M 0.9 2.7 24.6 7.1 1.8 0.0 37.1 
c 0.9 3.0 26.4 6.8 1.7 0.0 38.9 
1.0 3.1 23.8 7.2 1.8 0.0 36.9 
IT 1.4 3.2 27.6 11.7* 3.5* 0.3* 47.7* 
lli 1.4 3.0 29.2* 12.8* 4.5* 0.6* 51.7* 
AT 1.8* 2.9 33.6* 14.5* 5.2* 0.7* 58.6* 
pp 1.4 3.0 32.9* 12.4* 3.8* 0.2 53.7* 
PPM U.S 3.3 25.8 8.1 1.9 0.0 40.0 
Fe 1.4 3.7* 37.8* 11.9* 2.7* 0.2 57.8* 
OAC 1.4 3.4 31.6* 10.7* 3.2* 0.1 50.3* 
RA·NA 0.8 2.0*·# 18.1*•# 6.0 i.7 0.1 28.8* 
RA-Fe 0.8 2.0* 18.9*·# 7.2 2.2 0.1 31.3*•# 
RA·ACD 0.5 1.0* 15.0* 6.1 2.0 0.3 24.8* 
A global shift of synthesis towards highly sialylated and more branched chains in all conditions 
understates the information available from these results. Reviewing results in the context of 
contemporary understanding of both the underlying pathophysiological conditions and the 
mechanism from which microheterogeneity evolves disclosed additional conclusions. 
Identification of factors influencing microheterogeneity patterns. 
Results from pregnant women ( tables 8 & 9, figures 15 & 16 ) clearly show adaptation of 
transferrin glycan synthesis in the course of pregnancy. The tetra-sialotransferrin concentration 
increases despite its proportional decrease, the major part of the increase in the total transferrin 
. 55. 
concentration during pregnancy, however, is due to the increase in the concentration of highly 
sialylated transferrins. No significant change in the concentration of the desialylated transferrins 
is registered, which is consistent with an adequately functioning asialoglycoprotein scavenger 
system. 
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Figure 16. Transferrin microheterogeneity in the course of pregnancy. Numerals on X-axis indicate 
sialotransferrin fraction. 
Endocrinological influences on the microheterogeneity pattern, were further probed comparing 
women on oral contraceptives and women suffering from an isolated iron-deficiency anemia 
with controls and pregnant women (fig 17 ). In women on oral contraceptives the pattern 
changes in the same direction as in pregnancy, as such confirming the notion that oral 
contraceptives can influence the glycosylation system with reference to transferrin234. Compared 
to pregnancy, at the same level of increment of total transferrin concentration, the change in 
proportional representation was less marked in women using oral contraceptives. This 
difference in pattern may be related to the difference in the estrogen to progesterone ratio as the 
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latter is higher in pregnant women than in the OAC group. Progesterone has been reported to 
influence glycosylation, data on estrogen are limited to stimulation of total transferrin synthesis. 
Therefore the above described difference could be explained on the basis of these assumptions. 
Alternative explanations lie in the preponderance of other hormones in pregnancy. Prolactin 
can probably be excluded in view of the rapid normalization of the microheterogeneity pattern 
after delivery in lactating women, but as such endocrinological influences are certainly 
significant 
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Figure 17. Transferrin microheterogeneity in control females, iron deficiency anemia, women using oral 
contraceptives and women at term pregnancy. Groups indicated as in table 6. Top: 
proportional distribution of sialotransferrin fractions on the left and corresponding 
concentrations on the right 
concentrations respectively. 
Lower half: increments in relative amounts and actual 
As reflected in clinical chemical parameters, the rheumatoid arthritis groups comprise a 
spectrum of disease activity235·236 ; in order of increasing disease activity the nonanaemic, the 
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iron deficient and the ACD group. Changes in microheterogeneity are again similar in direction, 
but this time protein synthesis is significantly reduced as a concomitant feature of the acute 
phase reaction. As the alteration in glycosylation was more pronounced in the anemic groups 
with the ACD group displaying the greatest change in pattern, change in glycosylation of 
transferrin in RA appears to be correlated with disease activity ( figure 18 ), confirming 
conclusions drawn from studies on concanavalin A binding patterns of a1 acid glycoprotein237 . 
The decreased concentration of the disialo- and trisialotransferrin in RA is significant, and this 
also appears to correlate with disease activity. The latter can be interpreted as resulting from the 
activation of the asialoglycoprotein scavenging system in the acute phase reaction, thus working 
at higher efficiency. The higher avidity of this system as such for desialylated tri- and tetra-
antennary glycans238 may be an additional factor. 
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Figure 18. Transferrin microheterogeneity in control females and females with Rheumatoid Arthritis 
(RA) divided in three groups: non-anaemic RA, RA accompanied by iron defficiency and RA 
complicated by anemia of the chronic diseases. Groups indicated as in table 6. Top: 
proportional distribution of sialotransferrin fractions on the left and corresponding 
ccncentrations on the right Lower half: increments in relative amounts and actual 
concentrations respectively. 
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Regulatory aspects of N-glycosylation and protein synthesis. 
Evolutionary glycan synthesis is one step up the ladder compared to protein synthesis, 
particularly in its coding mechanism. Through both the possibility of branching and a 
combination of anomerous configurations and types of bonding between identical sets of 
components, a vast combination of structural determinants is created, as in other 
macromolecular synthetic machineries, but glycans are distinct from polypeptides and nucleic 
acids in the comparatively small size at which analogous astronomic diversity is attained. It is 
also distinct from nucleic acid and polypeptide synthesis in that it is not coded for by an 
accurate template mechanism. In essence glycan structure is coded for by intrinsic information 
laid down in the combination of primary, secondary and tertiary characteristics of the 
polypeptide core structure, in conjunction with characteristics of enzymes involved in the 
synthetic machinery as well as the interaction with the matrix in which it is processed. 
Consequently outcome is not explicitly defined, at the cost of loss of uniformity, hence the 
phenomenon of microheterogeneity. 
From this understanding it evolved that amongst others the results of the isoelectric focusing of 
serum transferrin can be appreciated as a means of assessment of the precision of control over 
the glycosylation system. Our results are based on a technique that provides a very accurate and 
reproducible measure of transferrin microheterogeneity. In view of the complexity of the 
synthetic system and its control, it is clear how little variation there in fact is in the 
oligosaccharide-structures attached to this particular protein. Although some heterogeneity is 
still hidden from isoelectric focusing, only 9 different fractions can be distinguished in iron 
saturated human serum. As shown in table 2, between and within single individuals the 
variation in this microheterogeneity is minimal. Also in all groups with established disease I 
physiological states the pattern of distribution was similarly remarkable in its uniformity. 
Variation in microheterogeneity can therefore not just be the result of random variation. The 
consistency of isoelectric focusing patterns characterizes the system in a broad sense, 
demonstrating that the process must be governed by a very potent control system, although the 
mechanism, apart from identification of constituting elements, is still beyond our perception. 
A second conclusion within the same context refers to the coupling between protein and glycan 
synthesis. Results on sera from pregnant women already indicate that protein core synthesis and 
change of glycosylation towards higher branched glycans are not linked, since the increment in 
the forms with tri- and tetra-antennary chains correlated better with duration of gestation than 
with concentration of total transferrin ( figure 19 ). Women on oral contraceptives attain a 
lower level of change in microheterogeneity when compared to that stage in pregnancy where 
total transferrin concentrations are similar, which indicates that changes in microheterogeneity 
and transferrin protein synthesis are not linked. 
The most persuasive argument is provided in the results from the RA-group. In acute and 
chronic inflammatory conditions increased synthesis of acute phase proteins is invariably 
accompanied by changes in the microheterogeneity spectrum, at the least not incompatible with 
a linkage. Transferrin being a negative acute phase protein239 , it provides the model in which 
the effect of protein synthetic rate on N-glycosylation is dissociated from the effect of the acute 
phase response on glycosylation. The microheterogeneity pattern can be changed markedly 
even when protein synthesis is significantly depressed. Therefore a fixed linkage between 
transferrin protein synthetic rate and glycosylation pattern can be denied. 
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Figure 19. Correlation diagrams displaying redirection of transferrin glycan synthesis related to duration 
of pregnancy ( top ) and to total transferrin concentration ( bottom ). The difference in the 
correlation to duration is significantly higher than the correlation to total transferrin 
concentration; p < 0.001. 
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Hypothesis on the role and rationale of glycosylation changes in relation to 
physiological and pathophysiological requirements for iron. 
Having concluded that observed changes in tranferrin microheterogeneity are not just related to 
random faults or a byproduct of increased synthetic rate, but the result of strictly controlled 
redirection of glycan synthesis, the next question that arises is whether these changes in 
transferrin have any functional significance, or is transferrin simply an innocent bystander as it 
happens to pass the synthetic machinery that has been adjusted for other reasons. To address 
this question results are reviewed in their pathophysiological contexts. 
Pregnancy 
The adaptation of the microheterogeneity pattern in the course of pregnancy in timing closely 
coincides with the major changes in iron metabolism as they occur during pregnancy. The 
increased demand of the fetoplacental unit and maternal bone marrow for iron is partly 
counterbalanced by cessation of menstruation. The remainder is partly met by increased iron 
absorption from the gut. The cumulated demand for iron may increase to above 8 mg/day, 
which exceeds the uptake rate from the gut. Therefore mobilization of iron from storage sites is 
an important mechanism in pregnancy, particularly in the later stages. The correlation between 
the increment in the production of highly sialylated transferrins and combined daily maternal 
and fetoplacental iron needs, combined with the absence of correlation with the production of 
tetrasialotransferrin, is striking ( figure 20 ). As both major iron requiring processes, i.e. 
maternal erythroblast iron uptake and iron uptake on the maternal side of the placenta have 
been shown to be dependent on the interaction between transferrin and the transferrin receptor, 
the obvious conclusion is to relate these changes in microheterogeneity to increased iron fluxes. 
This concept of redirection of iron fluxes through modulation of functional characteristics of 
the molecule without affecting the protein moiety and independent from its rate of production is 
one that has a certain attraction, but admitted, coincidental concurrence can certainly not be 
excluded and the concept must await experimental verification. However, some additional 
weight is added to the argument by observations in other diseases ( see paragraphs on iron 
deficiency anemia and RA ). 
Iron deficiency anemia 
Iron deficiency, if simply defined, is a state of global physical demand for iron in the organism. 
Having postulated a functional role for the change in glycosylation in iron metabolism via 
modification of functional characteristics of transferrin a dilemma is thus created: what 
rationale is there to account for the fact that changes in obviously the pre-eminently iron 
demanding condition are less prominent than in pregnancy ? 
The answer may lie in both the nature and the site of generation of the signal to adapt to the 
stress the organism is subjected to in each particular condition. In iron~deficiency the matter is 
above all to absorb more iron from the gut, and not such much to re-distribute as to distribute 
any of the available iron as all tissues are devoid of iron. Transferrin plays no direct active role 
in absorption of iron from the intestines, denying a role for changes in transferrin~substructure 
in it as well. Secondly, the single most important site of production of transferrin that ends up in 
the circulation is the liver, which controls transferrin protein synthesis. During pregnancy in 
essence the fetus, through regulation of the hormonal milieu in concert with the placenta, 
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controls the whole range of maternal metabolic, hematologic and even cardiovascular 
adaptations to pregnancy240. Regardless of the presence of anemia increased erythropoiesis is 
forced upon the mother, dictated by the fetoplacental unit. Even more so than in iron deficiency 
iron must be lured away from storage sites or preferentially be taken up by organs other than 
those involved in storage, explaining the logic for a physiological mechanism different to that 
in iron deficiency anemia. 
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Figure 20. Transferrin microheterogeneity in relation to transplacental iron transport during pregnancy . 
( ------ ) Transplacental iron transport in mg/day ( estimated figures based on data on 
transplacental iron transport241 ). ( o-o) Pentasialotransferrin production ratio. (•-•) 
Tetrasialotransferrin production ratio. Production ratio's are estimates from the ratio of actual 
subfraction concentration over initial subfraction concentration multiplied by a correction 
factor for increased vascular mass, assuming unaltered serum half lives of transferrins in the 
course of pregnancy. 
Rheumatoid arthritis 
Referring to the relative conservation of the production of highly sialylated transferrins, the 
above postulated facilitation of iron fluxes to the bone marrow through transferrin glycan 
modulation can also be incorporated in the interpretation with respect to rheumatoid arthritis. In 
view of the high correlation of disease activity and shift in microheterogeneity pattern, the 
conservation of highly branched glycans may form part of a compensatory mechanism in 
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anemias accompanying rheumatoid arthritis, attempting to facilitate a decreased erythroblast 
iron availability which has been postulated to be a major contributing factor in this condition. 
This decreased iron availability may rely on inhibitory effects of cytokines such as the 
interleukins and TNF, factors that have been shown to correlate highly with disease 
activity240•242 • The same mechanism would of course also operate in the disease stages not 
accompanied by ACD, but then be compensated for. In ACD this compensation appears to 
finally fall short. Of course this notion is based on correlations only and one could just as 
reasonably turn the argument around. For instance it can be postulated that anemia of the 
chronic diseases arises when the tetra-sialotransferrin concentration falls below a critical level. 
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Chapter 7. 
Microheterogeneity in vitro. 
Binding of purified microheterogeneous forms of 
transferrin to the transferrin receptor on placental 
microvillous transferrin receptors 
Uptake of iron from microheterogeneous forms of 
transferrin by a liver cell line 
Uptake of iron from microheterogeneous forms of 
transferrin by human bone marrow 
Iron binding by microheterogeneous forms of 
transferrin 
Transmembranous NADH diferric transferrin 
reductase activity in relation to micro heterogeneity 
Recombinant nonglycosylated transferrin 
From the inventory of the glycosylation patterns in the groups described above, it followed that 
changes in these pattern might be instrumental in modulation of iron metabolism. To further 
assess this possibility in vitro experiments were devised in keeping with the several functions 
known for transferrin: 
1. Transport-function; the three quantitatively most important target organs have been 
tested 
a. Binding to placental membrane transferrin receptors. 
b. Transferrin and iron uptake by liver cells. 
c. Iron uptake by bone marrow. 
2. Affinity for iron. 
3. Transferrin receptor associated NADH-reductase activation in liver cells. 
The bacteriostatic effect of the microheterogeneous forms of transferrin has not been compared. 
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As this is related to the chelating properties of the protein this will most probably be changed 
analogous to changes in iron affinity. Changes in prevention of spontaneous oxygen radical 
formation are highly unlikely since glycans can in no way influence the conformation of iron 
binding structures within the two domains. 
These topics are discussed in the above indicated sequence; an integration of findings and the 
interpretation within the context of iron metabolism is presented in chapter 8. 
Binding of purified microheterogeneous forms of transferrin to the 
transferrin receptor on placental microvillous transferrin receptors 
From human term placenta microvilli, vesicles with normal membrane orientation carrying 
transferrin receptors were isolated. Transferrin-receptors isolated can be expected to be 
saturated with maternal transferrin. A choatrope treatment therefore preceeded the usual 
isolation procedure before incubation with transferrin samples of interest. 
Membranes were incubated with either iodine-labeled 4 sialotransferrin or with iodine-labeled 
6-sialo transferrin. Both transferrins were fully iron saturated and in all experiments correction 
for nonspecific binding was performed in a simultaneous run in 200-fold excess of unlabeled 
diferric transferrin. 
In figure 21 results are shown in the Scatchard representation. 
0.05 
1OM Bound I free 
( pmol/mg/nM ) 0.03 + 
0.02 
0.01 
5 10 
Transferrin bound 
( pmollmg) 
Figure 21. Scatchard plot of binding data. Comparison between 4-sialo ( + ) and 6 sialotransferrin ( * ). 
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Table 10. Binding of transferrin subtractions to human placental microvilli transferrin receptor. 
transferrin fraction 
4 sialotransferrin 
6 sialotransferrin 
Ka ± s.e.m. (M-1 ) 
• I07 
2.4 ± 0.3 
1.4±0.8 
Tf R I mg pellet protein • 
wtz 
3.8 ± 0.4 
3.6 ± 0.3 
Association constants, number of binding sites and nonspecific binding were calculated from 
the data by nonlinear least squares analysis applying the Marquardt-Levenberg algorithm. 
Uptake of iron from microheterogeneous forms of transferrin by a liver 
cell line 
For determining the influence of microheterogeneity on iron uptake by liver cells in practice the 
choice is limited between isolating heterologous noncarcinomatous hepatocytes from perfused 
livers and homologous carcinomatous cell cultures. The initial choice for the human liver 
cancer derived cell line HepG2 is based on the preference for using a homologous model243 plus 
the fact that the HepG2 cell line expresses both major receptor systems involved in transferrin 
uptake in liver cells, i.e. the transferrin receptor and the asialoglycoprotein receptor system. 
HepG2-cells grown to confluent state in culture flasks were incubated with microheterogeneous 
forms of transferrin in the diferric form. Transferrin subtractions used were isolated by 
isoelectric focusing without prior separation on a concanavalin A column. Therefore 
heterogeneity within these fractions still present from partially desialylated forms has to be 
incalculated ( e.g. 5-sialotransferrin having lost one sialic acid residue in the 4-sialo fraction 
etcetera). 
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Figure 22. Iron uptake from 4-sialotransferrin by HepG2 cells. (*)total uptake, ( +) TfR-uptake and 
( • ) ASGPR-uptake. 
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In all experiments transferrins used were added to a concentration of 0,3 ~mol/l, which is 
known to provide saturation of the transferrin receptor with respect to the receptor mediated 
endocytosis of transferrin. 
In retrospect a higher concentration might have been a better choice since the transferrin 
receptor asssociated oxidoreductase reaches saturation at 4 ~mol/1. The small amount of 
transferrin available at the time restricted possibilities in that respect however, so that 
conclusions referring to NADH-reductase activity have been tested independently at a later 
stage. 
The total iron uptake from 4 Sialo-transferrin in the course of two hours incubation is shown in 
figure 22. 
For all fractions examined, correction for nonspecific uptake by subtraction of results obtained 
in presence of 200-fold excess unlabeled transferrin; transferrin-receptor mediated uptake was 
determined by including asialofetuin in the incubation-medium which also predicts the 
asialoglycoprotein receptor-mediated uptake. 
Identical time courses were found for the other transferrin fractions tested. The summary of the 
data obtained with all fractions is given in table 11. These are based on the determination of 
internalized iron after 2 hours of incubation at 37 °C, and all means of experiments in triplicate. 
Table 11. Iron uptake from transferrin by HepG2 cells ( pmol Fe I 106 cells I hr ; results are 
means of three experiments ) ASGPR = asialo-glycoprotein receptor. 
Transferrin fraction total uptake Tf R-mediated ASGPR-mediated percentage uptake 
uptake uptake of total via ASGPR 
2 Sial a-transferrin 1.43 1.18 0.25 17.5% 
4 Sial a-transferrin 1.77 1.60 0.17 9.6% 
5 Sialo-transferrin 1.69 !.54 0.15 8.8% 
6 Sialo-transferrin 1.55 1.48 0.07 4.5% 
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Uptake of iron from microheterogeneons forms of transferrin by human 
bone marrow 
Human bone marrow was incubated with 59Fe-labeled diferric 4 Sialo- or 6 Sialo-transferrin. 
The transferrin concentration in the incubation medium was I ~mol/l. Uptake was linear over 
the observed period of time. The internalization of iron from 6 Sialo-transferrin was equally 
effective. 
Iron uptake 
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Figure 23. Iron uptake by human bone marrow cells from 4 sialotransferrin (+)and 6-
sialotransferrin ( * ). 
Iron binding by microheterogeneons forms of transferrin 
Equilibration dialysis of 4 and 6 Sialotransferrin was performed according to Aasa et al244. 
Fractions were left to equilibrate for 5 days. 
The 6 Sialotransferrin displayed an affinity for ferric iron equal to that of the 4 Sialotransferrin. 
This is in agreement with the prediction based on the molecular chemistry of transferrins 245 . 
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Transmembranous NADH diferric transferrin reductase activity in 
relation to microheterogeneity 
Hepatocytes prepared from Wistar rats by regional perfusion of the liver with collagenase IV 
via the portal vein, followed by excision of the liver and isolation of hepatocytes. Viability as 
tested by the trypan Blue exclusion test was 90 %. Hepatocytes were incubated with 5 ~M 
diferric transferrin solutions and iron transfer to bathophenantroline was measured through the 
absorbance change at 535 nm and 4-sialo diferric transferrin was compared to 5-
sialotransferrin. 
Fe-BPS l (mkromol/1) 
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45 
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Figure 24. Formation of bathophenantroline disulphonate catalyzed by intact rat hepatocytes in the 
presence of 4-sialotransferrin ( +) and 5-sialotransferrin ( * ). 
A simultaneously performed uptake study identical to the experiment with HepG2 cells was 
performed on isolated rat hepatocytes, employing 59Fe-labeled diferric 4-sialo bi-bi-antennary 
and 6-sialo tri-tri-antennary transferrin. After a 2 hour incubation hepatocytes had shown a 
prefererence for uptake from 4-sialotransferrin compared to the 6-sialotransferrin (table 12 ). 
Table 12. 59Iron uptake from transferrin by rat hepatocytes ( pmol Fe I l 06 cells I hr ). 
Transferrin fraction total uptake Tf R-mediated uptake ASGPR-mediated % uptake of total via 
uptake ASGPR 
4 Sialo-transferrin 1.17 l.ll 0.06 5.1% 
6 Sialo-transfenin !.02 0.98 0.04 3.9% 
The uptake via the asialoglycoprotein receptor compared to the results obtained in HepG2 cells 
is lower. Probably the exhaustive purification of the transferrins used in this experiment 
accounts for this difference. 
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Recombinant nonglycosylated transferrin 
As a further step towards the understanding of the function of glycans in transferrin chemistry 
and in transferrin metabolism, we decided to study the biochemical, structural and physico-
chemical properties of human transferrin completely lacking the carbohydrate moiety. Attempts 
to enzymatically remove the glycans employing endoglucosidases either failed or rendered a 
denatured endproduct that could not be renatured, or the sugars were only partially removed. 
Similar results were obtained employing HF and various other chemical methods. 
Bacteria lack the Golgi system and therefore N-linked glycans are not found in bacterial 
products. Also if we managed to get the transferrin expressed in a bacterial expression system 
at low rates, conceivable upscaling of production would be comparatively easy in view of the 
simple nutritial demands of bacteria, as opposed to continuous cell lines. 
In collaboration with us Dr M.H. de Smit from our depatment has been able to isolate 3 E. coli 
strains endowed with plasmids containing eDNA's coding for either human serum transferrin, 
the N-terminal or the C-terminal half transferrin. Furthermore, the authentic amino acid 
sequence has been maintained246 • Induction of plasmid expression by the thermoinducible PL-
promotor gave rise to low yields. This promotor was initially chosen because in the uninduced 
state it will be 99 %repressed. Strict control of expression was considered essential because the 
bacteriostatic potential of transferrin, the plasmid carrying the eDNA might turn out to be a 
Trojan Horse to the E. coli. Indeed a bacteriostatic effect is registered upon induction of 
expression but this is probably of limited importance since the bacterium appears to be able to 
acquired enough iron from the medium to saturate the protein and thus neutralise this negative 
effect. 
Figure 25. Formation of inclusion bodies containing human a-glycotransferrin in induced E.coli LC137. 
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The induction method proved to be more problematic. The temperature shift to 42 oc necessary 
for induction of the PL-promotor, most likely through the heat shock response resulting in 
increased expression of chaperonins and proteases due to increased protein turnover transferrin 
yields remained low. After switching to the Ptac promotor which is chemically inducible at 28 o 
C, thus avoiding the problems related to the heat shock response, and use of the protease 
deficient E. coli strain LC137, production was stepped up to 60 mg of nonglycosylated 
transferrin per litre of bacterial culture. 
The interior of the bacterium more closely reflects the circumstances that prevailed in the 
reducing atmosphere that existed when life began some 3.5 billion years ago. As a result 
bacteria, in contrast to eucaryotic cells that arose in aerobic circumstances, besides not 
glycosylating proteins, also do not form disulphide bridges. Large proteins such as transferrin 
that can form 19 disulphide bridges will therefore be devoid of this important stabilizing 
mechanism. As a result, but also due to the action of bacterial chaperonins, the protein is not 
found in the cell in its native conformation but in a denatured state in large amorphous particles 
called inclusion bodies ( figure 25 ). After cell destruction by sanification more than 95 % of 
the recombinant protein is found in the insoluble fraction derived from these inclusion bodies. 
The protein has to be liberated from these bodies and to this aim it first needs to be denatured 
even further by means of dissolution in 8 M urea and reduction of disulphide bridges by 
dithiothreitol (appendix A). Under these reducing conditions the protein can be 
elctrophoretically separated from the bacterial proteins and we have been able to obtain the 
purified recombinant nonglycosylated human transferrin and its half molecules, as is shown 
clearly by the SDS-PAGE (figure 26) and the amino acid analysis (table 13 ). 
Figure 26. SDS PAGE of native transferrin and recombinant transferrins isolated from E.coli LC137. A: 
molecular weight markers. B: native human transferrin. C: recombinant human 
aglycotransferrin. 0: bacterial lysate from which complete recombinant protein was isolated. 
E: recombinant N-terminal half transferrin. F: Lysate from which E was isolated. G: C-
terminal recombinant half transferrin. H: correponding bacterial lysate. 
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Apart from acknowledging the supposition, based on the structure of the plasmid, that the 
authentic amino acid sequence has been maintained, the analysis also showed no detectable N-
acetylglucosamine and a carbohydrate analysis performed independently confirmed the 
nonlycosylated state of the protein. Upon induction of the recombinant transferrin in E. coli at 
28 °C ( but not at 42 oq the cell suspension develops a conspicuous brownish pink hue that 
resembles the salmon pink of diferric transferrin solutions. Although this is not conclusive as 
evidence that in its denatured state the recombinant transferrin is capable of binding iron, it 
does hint at the integrity of the iron binding site under these conditions. In the ensuing isolation 
procedure the protein is completely denatured and with it the capacity to specifically bind iron 
with high affinity is lost. 
Table 13. Amino acid analysis of recombinant transferrins ( mol aminoacid I mol protein ). 
Sums of Asparagine and Aspartate and sums of Glutamine and Glutamate are given because of 
interconversion of these amino acids in the hydrolysis procedure. The colour reactant employed 
yields low absorbance products for Proline and Cysteine and these were thus not determined 
( n.d. ). % deviation represents the cumulated difference between integer numbers of separate 
amino acids in the transferrin species compared to the reference values derived from figures 
based on the eDNA characterization by Yang et al31 • 
recombinant reference reference reference 
human values N terminal values C-terminal values 
transferrin serum Tf rTf serum Tf cTf serum Tf 
(cTD 
Lysine 53.7 58 25.9 27 26.9 31 
Histidine 18.0 19 9.2 9 8.7 10 
Arginine 24.9 26 10.6 !2 14.7 14 
Aspartate+NH2 74.0 79 35.3 24 + 12 42.2 21 + 22 
Threonine 30.2 30 12.9 13 !6.3 17 
Serine 40.4 41 20.2 2! 20.6 20 
Glutamate+NH2 57.8 59 28.5 18 +ll 32.4 25 + 5 
Proline n.d. 32 n.d. 20 n.d. 12 
Glycine 5 i .5 50 25.2 24 27.3 26 
Alanine 58.4 57 3!.7 32 25.3 25 
Cysteine n.d. 38 n.d. 16 n.d. 22 
Valine 44.7 45 22.7 22 22.3 23 
Methionine 9.4 9 5.8 5 5.3 4 
Isoleucine !4.6 15 7.8 8 7.6 7 
Leucine 55.2 59 30.7 29 29.5 30 
Tyrosine 26.0 26 15.2 14 12.0 12 
Phenylalanine 25.8 28 15.4 16 13.1 12 
Tryptophan 7.5 8 2.9 3 4.2 5 
Total 679 336 343 
Total minus Cys 592.1 609 300.0 300 308.4 309 
and minus Pro 
o/o deviation 3.6% 3.3% 5.5% 
from predicted 
values 
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Presently the renaturation procedure described in appendix A has yielded a water soluble 
product at a concentration of 3 ~g I litre, capable of retaining iron with high affinity after 
equilibrium dialysis. In view of the very low protein concentration a reliable estimation of the 
affinity constant cannot be given yet. We did establish that this iron was retained after dialysis 
against PBS pH 7,4, and that mobilisation followed quickly after mild acidification of the 
transferrin solution. Also the renatured protein reacts with polyclonal rabbit anti human 
transferrin, at the least indicative of restoration of some of its epitopes to the native state. 
The cells containing the N-terminal half transferrin eDNA also display the brownish pink 
discoloration after induction of protein synthesis, and protein isolated reacts with the polyclonal 
anti transferrin. The C-terminal half transferrin is also capable of reacting with the antibody, but 
that is presently the limit of our knowledge about these intriguing substances. 
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Chapter 8. 
Synthesis of structure - function relationships 
To what purpose are N-linked glycans present on transferrin. This has essentially been the issue 
we have been addressing. 
Previous studies had failed to identify a specific role for these structures. Clearance of aged 
transferrin molecules by the liver was the only function identified for the glycans. This specific 
routing to the liver is dependent on eventual desialylation of glycans with subsequent clearance 
via the asialoglycoprotein receptor system which is present on hepatocytes only. The 
pluripotent glycoprotein scavenging role of this receptor is currently being criticised. Direct 
evidence for such a role is not available. Probably more specific, physiologic ligands exise34 . 
With respect to transferrin metabolism, this receptor system has been overvalued in the past 
years. The asialoglycoprotein receptor system does not play a quantitatively important role in 
iron transport in healthy people. Firstly, the dissociation constant of the asialoglycoprotein 
receptor for bi-antennary chains is 10-6M, indicating that under physiological conditions 
nonsaturating concentrations of desialylated transferrins will prevail. Secondly this system 
does not select for iron containing transferrin molecules, so at least two thirds of transferrin 
taken up in this manner will have been apotransferrin. Thirdly many of the other circulating 
glycoproteins and lipoproteins predominantly carry tri-antennary glycans, often more than three 
per molecule. These glycoproteins are present in high concentrations compared to the 
transferrins carrying tri- and tetra-antennary glycans. Although the affinity of the lectin for the 
tri-antennary chains is higher, with a dissociation constant of 1 Q-9M, the relatively high 
concentrations of physiologic ligands will effectively diminish the importance of this receptor 
system for normal iron uptake. Furthermore transferrin is predominantly utilised in the bone 
marrow. The number of endocytotic cycles a molecule can endure being limited, it is 
conceivable that most of the transferrin will be catabolised in the bone marrow. Finally, 
employing carefully selected transferrin species even in vitro the asialoglycoprotein route is of 
little importance (table 13 ), further substantiating the notion that the latter system is of little 
importance in iron metabolism. Thus, having stripped glycans of their alleged function in 
facilitating glycoprotein scavenging, one might conclude that for transferrin glycans, and by the 
same token changes in transferrin microheterogeneity, are of little physiological relevance. 
An interesting fact is that one of the other major transport proteins, albumin, is not glycosylated 
at all. However, individuals synthesising N-glycosylated albumin have been detected by chance 
in healthy volunteer populations. Analysis of their albumin gene sequence has revealed that in 
these rare individuals a single site mutation has created an N-glycosylation site not present on 
normal albumin. Nevertheless, no difference in its transport function could be detected. 
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Albumin, as opposed to transferrin, is an inert nonspecific carrier. Selection for 
nonglycosylated protein in the case of albumin will be rewarded with a decrease in cellular 
energy expenditure as the building of glycans is a highly exergonic process. Despite this 
possible advantage, transferrin in all animal species examined carries at least one glycan per 
molecule, suggesting some evolutionary advantage must exist in relation to one of the 
physiological functions of transferrin. 
As described in previous chapters, our approach has been to first study the rnicroheterogeneity 
patterns in vivo. Our results indicate that changes in these cannot just be attributed to random 
faults in the complex coding system or to increases in synthetic rates. Instead changes in 
microheterogeneity are the result of a strictly controlled redirection of glycan synthesis. In view 
of the concurrence of changes in transferrin glycan structure and transplacental transport, and 
the relative conservation of the transferrin with highly branched glycans in rheumatoid arthritis, 
redistribution of body iron stores to bone marrow and placenta as a result of changes in the 
microheterogeneity pattern of transferrin was considered a possible mechanism. 
On first inspection e~perimental results do not appear to favour this concept. Compared to the 
normally predominant form those transferrins becoming more abundant during pregnancy have 
lower affinity for the transferrin receptor on placental microvillous membrane, both in humans 
( table 10 ) and in the guinea pig247 . Although in vitro the affinity for the transferrin receptor 
decreases by a significant 42 %, a shift towards the 6 sialotransferrin will not lead to decreased 
placental or bone marrow iron uptake. In vivo no difference will exist because the receptor 
affinity is in such an order of magnitude that it will at prevailing diferric transferrin 
concentrations ensure constant full occupancy of exposed transferrin receptors. Also, 
endocytosis and exocytosis rates of diverse transferrins have been shown to be identical247 . 
With this established, van Dijk et al were able to show that in cells relying on receptor mediated 
endocytosis for iron uptake, once bound to its receptor, all rnicroheterogeneous forms of 
transferrin will behave identical with respect to iron donation. 
Finally, particularly with respect to pregnancy and other conditions accompanied by similar 
changes in glycosylation, the role of the transferrin receptor itself must also be taken into 
consideration. The observed affinity constants for the placental transferrin receptor are higher 
than values reported for reticulocytes. Possibly, this is due to changes in the end processing of 
the 3 N-linked glycans of the transferrin receptor itself as it has been shown that this influences 
the affinity of the placental receptor for transferrin248 . Increased branching of glycans results in 
increased affinity of the receptor for its ligand, and this intrinsically compensates for the 
negative effect of the simultaneously changed glycosylation of transferrin. Whether the same 
applies to maternal bone marrow cells in the course of pregnancy remains to be investigated. 
The latter may be plausible or even likely, but this interpretation should certainly be verified, 
amongst others because organ specific differences in glycosylation exist that may be additional 
factors determining receptor ligand interaction. For instance, human placental glycoproteins 
contain only the Sia c<2~3 Gal linkage whereas in serum glycoproteins both the Sia a6~3 Gal 
linkage or the combination of Sia a6~3 Gal and Sia a2-73 Gal linkages are found9R. 
In summary, facilitation of iron fluxes to the bone marrow or placenta due to preferential or 
faster uptake from transferrin at these sites is not present. Upregulation of transferrin receptor 
density in target organs as a result of hormonal influences is an additional possibility, and this 
may indeed be present, but this alone would not explain redistribution of iron stores as this 
must include mobilisation of iron from intracellular ferritin. A similar argument holds for iron 
mobilisation in conditions leading to iron deficiency, and these are often not even accompanied 
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by changes in transferrin microheterogeneity. The body of cells constituting the iron stores 
would thus seem to play a pivotal role in this, and as most of the iron stores are present in the 
hepatocytes, iron uptake from various transferrin subfractions was studied in detail. 
The liver cell iron uptake from transferrin is dependent on both specific uptake via the 
transferrin receptor and specific uptake via the asialoglycoprotein receptor. Uptake via the 
asialoglycoprotein receptor does not play a quantitatively important role in physiological iron 
homeostasis, transferrin receptor mediated iron uptake is therefore decisive in the interaction. 
We have established that transferrin rnicroheterogeneity does influence hepatocellular iron 
uptake form transferrin. In a liver carcinoma cell line we found a 7.5 % difference between 4 
sialo and 6 sialotransferrin mediated iron uptake via the transferrin receptor, and an 
intermediate value was found for the 5 sialotransferrin. In isolated rat hepatocytes the 
comparable figure was II % as assessed by the ability of bathophenantroline to chelate iron. 
Although these differences are small, and also taking into consideration the fact that 6-
sialotransferrin constitutes only 8.6% of the total transferrin by the end of pregnancy, still this 
may have a profound effect on the distribution of iron over the body because the liver besides 
continuously taking up iron also continuously excretes iron. A small effect on the uptake may 
therefore have a much profounder effect on the net balance figure. 
Why then would the liver behave different from the placenta and the bone marrow with respect 
to its iron uptake from diverse microheterogeneous transferrins ? As described in chapter 3, the 
predominant mode of iron uptake in the liver differs from that of placenta and bone marrow. 
Although the components of the system have not been identified yet, uptake of iron by the 
hepatocyte is consistent with release of iron from transferrin at the cell surface. Whether or not 
this involves reductive release is not settled, but also not relevant in this context. The main 
point is that since the mechanism differs from iron uptake through receptor mediated 
endocytosis, an alternative behaviour of transferin with respect to iron donation to hepatocytes 
is conceivable. If transfer of iron to bathophenantroline disulphonate by isolated rat hepatocytes 
indeed correlates with the activity of the transplasmalemmal NADH oxidase activity, as Sun et 
al maintain 154, than the following proposition may provide a biochemical mechanism operative 
in the distribution of iron between sites of absorption, storage and utilisation. Presently we have 
not yet been able to compare diferric transferrin stimulated NADH oxidase activity for the 
various microheterogeneous compounds, but for the moment it is inferred from the decreased 
transfer of iron from 5 sialo transferrin when compared to transfer from 4 sialotransferrin to 
bathophenantroline disulphonate by intact hepatocytes that this may lead to increased NADH 
levels intracellularly and acidification of the cytoplasm. This in turn may influence the 
mobilisation of iron from ferritin which is also NADH and pH dependene49 , thus not only 
decreasing iron uptake but possibly also increasing efflux of iron from the hepatocyte (figure 
27 ). Such a link between transferrin structure and ferritin metabolism as a result of this 
intrinsic endocrine action of the molecule defined and modulated by the structure of glycans 
attached to it will be a target for future investigations. 
Applying this model to pregancy, the forced mobilisation of iron from the liver can be 
envisioned as being due to increased concentrations of the highly sialylated transferrins that are 
as competent as the ordinary 4 sialotransferrin in delivering iron to bone marrow and placenta, 
but lag behind with respect to iron delivery to the liver. The liver efflux remaining constant or 
even increasing as a result of increased intracellular NADH/NAD+ ratio, even small effects 
over long periods of time will lead to significant diminution of liver iron stores. It also accounts 
for iron taken up in hepatocytes via other routes than transferrin, which may be significant in 
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view of the fact that it is still unclear by which way iron taken up from the gut enters the 
circulation and via which route in then reaches the liver and eventually transferrin. 
In iron deficiency anemia, mobilisation of iron may result from the decreased saturation of 
serum transferrin. In this condition ( but also in pregnancy ) it is noteworthy that the hepatic 
(reductive) release mechanism is saturated at 3~M, whereas the receptor mediated endocytosis 
is fully saturated at 0.3 !J.M. As transferrin saturation falls below 10 % in developing iron 
deficiency, the point is reached where diferric tetrasialotransferrin concentration becomes too 
low to keep hepatic transferrin receptors continually occupied, with the above indicated 
sequence leading to increased mobilisation of iron from ferritin as a result. Thus at low serum 
transferrin saturation liver uptake will be decrease more than bone marrow uptake, possibly in 
combination with activated mobilisation from hepatocytes. Likewise peripheral tissues may 
suffer from the great avidity of bone marrow for iron as a result of its specialised mode of iron 
uptake, and in that context the phenomenon of latent iron deficiency can be placed. 
Hepatocyte 
NADH 
Traosplu.1malemmal 
NADH oxidu.oe 
Fe inllux 
ferritin 
Fe eftlux 
Figure 27. A hypothesis on the mobilisation of liver iron stores as a result of modification of ratios 
between microheterogeneous forms of transferrin. Binding of transferrin to its receptor activates the 
transplasmalemmal NADH oxidase. Under saturating conditions net activity will nevertheless decrease 
when the amount of highly sialylated transferrins increases as these activate the transplasmalemmal 
NADH oxidase to a lesser degree (figure 24) leading to an increased NADH/NAD+ ratio, which through 
its link via the FMN:NADH oxidase may lead to increased mobilisation of ferritin iron and increased iron 
efflux. Together with the measured decrement in iron uptake from transferrin as a result of increased 
glycan branching this results in both mobilisation and depletion of iron stores. 
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The physiological significance of the N-linked glycans, and changes observed in various 
conditions may be extended beyond the above described concept when other functions of 
transferrin are taken into consideration as well. In particular the growth stimulating effect of 
transferrin makes a good candidate for being susceptible to changes in microheterogeneity. Not 
addressed is the possibility that glycans may be important in the stabilisation of the C-terminal 
domain, but if present one could hardly expect microheterogeneity shifts to play any role in that 
field. For the moment we have identified one possible function of theN-linked glycans in iron 
homeostasis and hope to be able to study more structure function relationships in the near 
future employing the recombinant transferrins. 
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Summary 
Combining available knowledge on the role of transferrin in iron metabolism and observations 
on the variability of the structure of transferrin N-linked glycans in a number of physiological 
and pathophysiological conditions, it is conjectured that these covalently linked 
oligosaccharides may play a decisive role in the perpetual redistribution of iron over sites of 
storage and utilisation in the body. 
Additional in vitro experiments, assessing the interaction between transferrins distinguishable 
on the basis of differences in N-linked glycan structure and cells derived from its major target 
organs, support this notion. A possible biochemical mechanism involved in this regulating 
activity is pointed out as well by results obtained. 
Conclusions: 1. Variation in the structure of transferrin linked glycans is a tightly governed, 
non random process. 
2. The glycans constitute an adjustable signal attached to the protein capable of 
modulating iron fluxes in the body. 
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Samenvatting 
Op grand van observaties betreffende de variatie in de structuur van aan transferrine gebonden 
glycanen in verscheidene physiologische en pathophysiologische condities is, vanuit de huidige 
stand van kennis omtrent de plaats van het transferrine in het ijzermetabolisme de hypothese 
opgesteld dat deze covalent aan transferrine gebonden oligosacchariden een bepalende rol 
zouden kunnen spelen in de uit normaal celverval voortvloeiende voortdurende herverdeling 
van lichaamsijzer over diens opslag- en verbruikscompartimenten. 
Aanvullende in vitro experimenten, waarin het gedrag van verscheidene op grond van 
verschillen in glycaan-gedeelte gedefinieerde transferrinen ten opzichte van de belangrijkste 
doelorganen is geevalueerd, verlenen steun aan deze hypothese. Daarnaast vestigen deze 
resultaten ook de aandacht op een biochemisch mechanisme dat aan bovengenoemde 
regulerende rol ten grondslag kan liggen. 
Conclusies: 1. Variatie in de structuur van aan transferrine gebonden glycanen is een strikt 
en doelmatig gereguleerd proces. 
2. In zijn structurele variatie vormt dit aan het eiwitmolecuul toegevoegde 
kenmerk een modificeerbaar signaal dat de verdeling van ijzer over 
lichaamscompartimenten kan moduleren. 
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Appendix A: Materials and Methods 
Patients. 
After acquiring informed consent, blood was obtained from 21 healthy volunteers, 8 male and 13 female, 56 pregnant 
women attending the University Hospital Obstetrical Clinic, 7 women using oral contraceptives, 9 women with iron 
deficiency anemia, and 18 female patients with rheumatoid arthritis fitting the revised ARA-criteria250. Anemic 
pregnant women and pregnant women with a latent iron deficiency were excluded by hemoglobin and serum ferritin 
measurements. The course of pregnancy and delivery was uncomplicated in all cases. All 18 female rheumatoid 
arthritis patients had active disease and used non-steroidal anti-inflammatory drugs, as well as long-acting anti-
rheumatic drugs. Other causes of anemia were excluded by history taking (present or past ulcer disease or other 
complaints or signs of gastrointestinal diseases, hypermenorrhoea and haematuria), negative stools for occult blood, a 
normal vitamin B 12, folic acid, Coombs test, creatinine clearance and absence of microscopic hematuria. The female 
rheumatoid arthritis patients were divided into three groups of six: nonanemic patients, patients with iron deficiency 
anemia and patients with anemia of the chronic diseases. This distinction has been made on established criteria based 
on hemoglobin, serum transferrin and serum ferritin measurements235·251 . 
Statistical analysis. 
Total transferrin concentrations were compared using the two tailed Student Hest, and non-parametric data by the 
Mann-Whitney U test. Coefficients of correlation were compared using Spearman's test. 
Sample treatment 
Venous blood samples were obtained between 10.00 and 12.00 hour in glass tubes not containing anticoagulant. 
Omitting the anticoagulant is a relevant part of the procedure as we and others have found that the addition may 
influence the isoelectric focusing252. After clot retraction, the sample was centrifuged for 20 minutes at 1200 g and 
4"C. The serum was used immediately or stored at -20°C, or -70"C until use. Before storage or application on the gels 
complete iron saturation of the transferrin was ensured by mixing 100 111 serum with 5 111 of 0.5 M NaHC03 and 3 111 
of 10 11M Fe(III) citrate which was then left at room temperature for 1 hour. Rabbit anti human transferrin-anti sera 
were home made and have been compared favourably with anti sera from Dako, Denmark. 
Analytic isoelectric focusing and crossed-immunoelectrophoresis 
This method involves two phases combining two electrophoretic techniques; the first establishing separation of 
proteins of interest, the second run perpendicularly to the first for identification and quantification purposes. 
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In the first phase the transferrin subtractions were separated on polyacrylamide gelstrips on an immobilized pH-
gradient by isoelectric focusing. 4 mm wide strips cut from an lmmobiline Dry Plate, pH 4.9-6.1 (purchased from 
LKB-Produkter AB, Bromma, Sweden), which had previously been rehydrated in aqua bidest to a final weight of 20 g 
per gel, were placed on a thermostatic template kept at l0°C. Anode and cathode strips soaked in 10 mM glutamic 
acid a;1d 10 mM NaOH, respectively, were placed over the ends of the Immobiline strips. 2 )Jl of the iron-saturated 
serum was applied at the cathodal side of the strips. A voltage of 1 kV was applied during 18 hat 1 ooc. 
For the second phase of the electrophoretic procedure, 60 ml of a l% (w/v) solution of Agarose-M (LKB) in 24-mM 
sodium barbiturate-HCl buffer pH 8.7 prepared at 100°C were cooled to 55°C, whereupon a preheated (55°C) amount 
of the rabbit anti-human transferrin preparation was added and thoroughly mixed with the agarose solution. This 
mixture was poured onto a preheated glass plate (130 mm x 260 mm) placed on top of a second glass plate kept at 
50°C. Then the lmmobiline strips from the isoelectric focusing step, having been soaked for 15 min in the electrop-
horesis buffer, were placed upside down on the agarose surface. The crossed immunoelectrophoresis is carried out in 
the 24-mM barbiturate-HCl buffer during 4 hat l0°C at a voltage of 12-13 Vlcm. All determinations were done in 
duplicate. The fractions were successively quantitated via measurement of the areas enclosed by the 
immunoelectrophoretic peaks. 
Alternatively, relative amounts can be determined by immunoprecipitation of transferrin directly after ending the first 
phase-separation. To this end, samples must be diluted 1 10 before application on the immobiline strips. After the 
isoelectric focusing strips were covered with 50 )11 rabbit anti human transferrin solution (purchased from Dako, 
Copenhagen, Denmark, titre 2800 ). Dilution of the sample is necessary as antigen excess may cause centres of the 
predominant subtractions to dissolve during the following wash in saline after which the gel is left in saline overnight. 
Bands were stained in a solution of 12% (w I v) trichloroacetic acid containing 0.1 % Coomassie Brilliant Blue G-
250, followed by staining with Coomassie Brilliant blue R-250, and finally rinsed with demineralized water and air 
dried. 
Transferrin bands have been quantified with the Ultroscan XLaser Densitometer. Results were processed using the 
Gelscan XL (2.1) software (both purchased from Pharmacia I LKB ). 
Protein concentrations 
Transferrin concentrations were measured turbidimetricaHy253 using the Boehringer ES22. For this transferrin was 
immunoprecipitated with sheep-anti-human-transferrin ( purchased from Boehringer ) in an 0. J M Na2HP04 I 
KH2P04 bufferr pH 7.5, containing 4% polyethyleneglycol. Ferritin concentration~ were measured by ELISA. 
Known transferrin functions are concentration dependent processes. Thus in all groups individual concentrations have 
been equated from fractional ratios and total transferrin concentration. In pregnancy and other groups this adjusts the 
effects to its physiological proportions, as fraction ratios ( assuming unaltered, similar serum half lives ) describe the 
relative adaptation of synthesis, but in conditions where total protein synthesis increases or decreases as well, this 
presentation does not correctly reflect physiological changes. 
Preparative isoelectric focusing 
Five em wide strips were cut from precast Immobiline Dry Plates pH 4.9 - 6.1. Gels were rehydrated with 
demineralized water. Concentrated diferric transferrin c1 ( 125 gramll in lOmM NaHC03 I NaCl solution , pH 8.0) 
was applied directly on the gel surface 1 em from the cathode over a width of l em. A voltage of 2 kV was applied. 
Succesive applications of I 00 )ll transferrin-solution were possible when exuded droplets of transferrrin-solution were 
removed from their respective focusing positions twice daily. Also, excess solvent from previous applications was 
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removed before repeat applications using dry electrode strips and simultaneously elctrode strips were resoaked in 
appropriate solutions. Under these conditions focusing was allowed to continue until all of the sample had been 
applied and focused (in total4 days, twice daily application of 100 !ll ). 
Exuded droplets of transferrin solution were removed daily by absorbtion in dry pieces of electrode strip, which were 
then stored in closed tubes at -20°C. For recovery these electrode strips were simply eluted with a buffer solution. 
Concanavalin A affinity chromatography. 
Transferrin isolated from serum by immumoaffinity chromatography was separated in to the following three fractions: 
nonbinding, weakly binding and strongly binding following the procedure described by Hatton and Berry. Diferric Cl 
transferrin dialyzed against 0.05 M Tris/HCl, I M NaCl, lmM CaCl2 , lmM MnCI2 , lmM MgCI2 , pH 7.6. 
approximately 1 mg diferric transferrin/ gram wet gel was loaded on the Sepharose concanavalin A column. The 
column was equilibrated with 0,05 M Tris/HCI/ I M NaCI, lmM CaCI2, lmM MnCl2, lmM MgCI2, pH 7.6. 
Fractions of 5 ml were collected. Most of the transferrin ( about 76 % ) was eluted only after adding a-methyl-
glucopyranosyl to a concentration of 0.15 M to the equilibration buffer. The nonbound and the weakly bound fractions 
amounted to approximately 4 and 20 %respectively. 
Differentiation of occupation of iron binding sites in serum and bone marrow. 
For the analysis of iron distribution, serum or plasma, or bone marrow derived serum was diluted with an equal 
volume of anti-albumin antiserum raised in a rabbit by repeated intradermal injection of human albumin. 
Isoelectric focusing was performed in a Phastsystem with Phastgels pH 4 - 6.5 and pH 5 - 8 ( Pharmacia I LKB, 
Uppsala Sweden ). These are polyacrylamide gels saturated with mixtures of ampholines to create the pH-gradient 
when subjected to an electrical field. Using immobiline derived pH-gradients has not produced reliable results with 
respect to the analysis of the occupation of iron binding sites, uptake of iron from these precast gels possibly providing 
one of the main, unavoidable obstacles. 
For the analysis of iron distribution in a Phastgel IEF 5 - 8, the following program was adopted: 
Sample applicator down at step 1.2 OVh. 
Sample applicator up at step 1.3 OVh. 
Separation step 1.1 2000 V, 2.0 rnA, 3.S W, lS°C, 58S Vh. 
Separation step 1.2 200 V, 2.0 rnA, 3.5 W, !S°C, 15 Vh. 
Separation step l.3 2000 V, 2.0 rnA, 3.5 W, l5°C, 450 Vh. 
The four ( tetra-sialo) transferrin bands that can be discerned on the basis of differences in iron content in serum and 
in bone marrow were quantified with the Ultroscan XLaser Densitometer. Results were processed using the Gelscan 
XL (2.1) software. 
Amino acid analysis. 
For an elaborate description see reference 254. In short, amino acids and hexosamines have been assayed in a single 
run on a Multichrom M Analyzer (Beckman, MUnich, FRG) with a column (60 x 0.4 em) filled with Dionex DCIA 
resin (Dionex Corp., Sunnyvale, CA, USA). After acid hydrolysis N-Acetyl-glucosamine was determined as glu-
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cosamine. Peak areas were integrated automatically by an Infotronics CRS 210 Integrator. Sample volume 250 111. 
Analyses have been performed in triplicate. Analysis of a calibration mixture with sialic acid, mannose, galactose and 
glucosamine added in the same composition as expected in transferrin resulted in a recovery of glucosamine of 82 % 
and in the presentation of results this recovery percentage has been compensated for. Values are all from 24 hour 
hydrolysates, thus avoiding error$ introduced by extrapolations necessary to correct for hydrolysis time influences. 
Carbohydrate analysis. 
Hydrolysis was performed in hydrolysis tubes containing samples of 50~300 11g protein, equalling 2.5-25 nmol of 
individual carbohydrates, in 550 11! aqua bidest. Protein concentration was determined by measuring the E280. Next 
followed addition of 100111 100% trifluoroacetic acid and the tube was degassed at -30 oc and sealed. After a 2 hour 
hydrolysis contents were quantitatively transferred into a tube of a vacuum rotary evaporator and evaporated to 
dryness at 30-50 oc, and subsequently dissolved in 100 ).ll aqua dest, after which 1 rnl absolute ethanol was added. 
Analyses have been performed on an adapted Multichrom M (Beckman, Miinchen, FRG) with a reaction coil of 5 
metres and a diameter of 0.75 mm, a 30 metre teflon coil at the photometer outlet as backpressure coil to prevent air 
bubbles and a 60 ern long column with a diameter of 4 rnm filled with Aminex A~6 resin that has been converted into 
its trimethylammonium form by treatment of the resin with a 2 molar trimethylammoniumchloride solution, pH= 9. 
The eluant composition was ethanoJJwater in a ratio of 89/11. Flow rates of 25 mllh at 75 °C, or 16 ml/h at 60 oc have 
been applied. The eluant must be degassed before use. The colour reagant consisted of 0.02 % (w/v) p~anisyl 
tetrazoliumchloride in 0.18 moll! NaOH which has to be refreshed weekly. Reagent flow 4 mllh. The column eluate 
was measured at 570 nm, peak area comparison was performed with an Infotronics CRS 210 Integrator. The sample 
volume applied is 250 fll. 
For the spectrophotometric determination of sialic acid in transferrin the optimum hydrolyzation procedure was found 
to be mild acid hydrolysis 0.0 I M sulfuric acid at 70°C for 3 hours. Sialic acid determination was performed 
according to the method described by Horgan227 
Bone marrow samples and incubation with transferrin subfractions. 
Healthy donor bone marrow was obtained by aspiration from the iliac crest. Cells were immediately transferred to 
heparinised Hank's medium. Cells were washed in Hank's medium with 20 mM HEPES pH 7.4 before incubation and 
resuspended in this buffer and divided in fractions for incubation with either 4 -sialo diferric transferrin or 6-sialo 
diferric transferrin at a final concentration of I )..LM at 37°C under 95% oxygen and 5 % carbondioxide. Nonspecific 
uptake was corrected for by a simultaneous experiment with a 200 fold excess of unlabeled diferric transferrin. The 
experiment was performed in triplicate. 
At set times samples were taken and the reaction was stopped by the addition of ice cold PBS. Cells were washed 3 
times with ice cold PBS and spun down at 200 g for 10 minutes at 4 oc. 
Internalized iron was assessed by gamma counting of the remaning cell pellet. Protein determination of each pellet was 
subsequently performed and results were normalized to counts per minute per mg protein. 
Hepatocyte culture and hepatocyte incubation with transferrrin species. 
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HepG2 cells were grown to confluence in culture flasks. 24 hours prior to incubation experiments 3H 
thymidine was added to the medium. Experiments were carried out in DMEM with 10% fetal calf serum 
added. 59Fe labelled diferric transferrins were added to the culture flasks at t = 0, to a final concentration of 
0.3 !J.M. Nonspecific uptake was corrected for by a simultaneous experiment with a 200 fold excess of 
unlabeled diferric transferrin. Asialoglycoprotein receptor mediated uptake was detremined by 
simultaneous experiments with additional asialofetuin. At set times flasks were put on ice and rinsed with 
ice cold PBS 3 times. Then cells were harvested after a 5 minute trypsin incubation and washed again with 
cold PBS. Iron uptake was determined from the gamma counter and normalization of values for differences 
in pellet size were performed on the basis of j3-scintillation from incorporated 3H thymidine. 
Rat hepatocytes were isolated as described below and incubated with 59Fe labelled diferric 4 and 6 
sialotransferrins in PBS pH=7.4 for two hours at a final concentration of 5 )lM at 37°C under 95% oxygen 
and 5 % carbondioxide. Nonspecific uptake was corrected for by a simultaneous experiment with a 200 
fold excess of unlabeled diferric transferrin. Asialoglycoprotein receptor mediated uptake was detremined 
by simultaneous experiments with additional asialofetuin. At set times aliquots were drawn, then 
centrifuged at 2000 g for 15 minutes. Cells were resuspended and washed briefly in ice cooled PBS and 
centrifuged. This was repeated once again after which cells were finally pelleted abd separated from 
supernatant for ')'-canting. Total pellet protein was determined in all pellets separately after this and results 
wre normalized for these values. 
Preparation of placental brush border vesicles 
Full term human placenta was put on ice and transported to the lab in 20- 30 minutes after delivery. The 
isolation of microvillous membrane is based on the method of Smith et at255 The placenta is rinsed with ice 
cold PBS. Villous tissue fragments of 5- 10 mm size are cut from the maternal side of the placenta, rinsed 
in PBS and then left in 5 % C02 I 95 % 0 2 - gassed Hanks, pH 7 .4. Usual harvest produced 70 - 120 
grams of placental villous tissue. 
This tissue was rinsed 3 times with 0.1 M CaC12, then 3 times in PBS and finally resuspended in 150 m1 
PBS. All solutions kept at 4 oc. Using a magnetic sirrer, the solutions is stirred for 30 minutes, large tissue 
fragments are disposed of. 
Next the suspension is filtered through nylon mesh ( pore-size 90 )lm ). The filtrate is kept and centrifuged 
at 800 g for 10 minutes. Supernatant is separated from pellet and the former is centrifuged at 10,400 g for 
30 minutes ( 60 Ti Rotor 10,500 :rpm, brakes off). Pellet and supernatant are separated and supernatant is 
centrifuged at 110,000 g for 30 minutes ( 50.2 Ti rotor 31,000 rpm, brakes off). Supernatant is discarded 
and pellet is suspended in PBS. A Potter-Elvehjem homogeniser ( 40 sec at 25 rpm, clearance 0.004- 0.006 
inch) was used in all resuspension steps. 
Choatropous treatment consisted of resuspension of pellet in 0.2 M NH4SCN, incubation in this medium 
for 10 minutes, followed by pelleting membrane vesicles by centrifugation at 110,000 g for 30 minutes. 
This step was repeated once, after this pellet was resuspended and homogenized in PBS and used directly 
in assays or kept at -20 oc until use. 
Transferring binding studies 
Purified diferric transferrin subfractions were 1251-labeld employing the lodogen-method. After reacting preparation 
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were immediately loaded on a Sephadexx G 100 column and eluted with PBS pH=7.4. Eluant was collected in 
fractions that were tested for radioactivity and transferrin containing fractions were subsequently transferred into 
dialysis membranes. Dialysis against 3 changes PBS pH=7.4 for 24 hours followed to ensure optimal removal of 
unbound iodine. Specific activities obtained ranged from 800-1000 cpm/nanogram Tf. 
For the binding assays stored suspended frozen placental membrane vesicles were thawed, stimed and then pelleted by 
centrifugation at 110,000 g for 30 minutes ( 50.2 Ti rotor 31,000 rpm, brakes off). Supernatant was discarded and 
pellet suspended in PBS. For each sample resuspended solution to a volume containing 100 j.lg membrane vesicle 
protein was added, and total endvolume was 230 111. After addition of labeled transferrin the mixture was left at 22°C 
for 1 hour, followed by centrifugation at 110,000 g for 30 minutes. Supernatant was spearated from pellet, and the 
pllet rinsed 3 times with PBS pH 7.4 , supernatant from rinses was added to inital supernatant. 'Y-Counting of pellets 
and supernatants provided data for calculation of bound and free transferrin. Data for bound transferrin were all 
normalized to pellet samples 100 J.lg membrane vesicle protein by protein determination of all separate samples. 
Nonlinear regression analyis of data was performed on the basis of these data using the softvvare contained in the 
SPSS-program (Marquardt-Leventhal algorithm). Results in table are means from three separate experiments. 
Indirect assesment of NADH-oxidase activity of transferrin species 
Hepatocytes were isolated from male Wistar rat by the method of Berry and Friend257. Cells were finally supended in 
buffer containing 50 mM HEPES, 110 mM NaCl, 5 mM KCl, 0.74 mM MgCI2, 1,26 mM CaCI2, I% BSA, pH 7.4. 
5 · 106 cells /ml were incubated at 37 °C with 1 mM batophenantroline in the absence or presence of either 4-sialo or 
5-sialo diferric transferrin at a concentration of 5 ).LM. Aliquots of cell suspension were taken at set times and 
centrifuged in an Eppendorf centrifuge 5414 for 15 seconds. The absorbance of the clear supernatant at 535 nm was 
then determined. Results from three consequtive experiments are shown. 
The millimolar extinction coefficient of the iron-bathophenantroline complex at 535 nm used in equations was 22.14 
cm-lmM-1. 
Equilibrium dialysis 
Transferrin subspecies isolated by isoelectric focusing were dialyzed against 2 changes of EDT A, 3 changes of 
demineralized water and 1:\vo changes PBS. Dialysis membranes were filled with determined quantities of respective 
sialotransferrin variants and then dialyzed against a ferric iron solutions for 5 days. Concentration of protein and iron 
in the dialysis cell and in the dialysate were determined and affinity constants determined according ti44. 
Isolation of recombinant human transferrin from E. coli 
A 25 ml sample of E.coli ( LC 137) in LC medium was grown overnight in an airshaker at 37 °C. After 22 hours this 
culture was added to 1 liter of LC medium containig 0.84 mM IPTG. Cells were grown overnight and harvested in an 
MSE Coolspin centrifuge at 2600 g for 15 minutes. Cells were resuspended in 10 mls 50mM Tris/HCl, l mM EDTA, 
250mM NaCl, 5 mM DTT, pH 8.0 and disrupted by adding 100,000 U lysosyme.after a 30 minute incubation this 
mixture was snap frozen in carbice cooled ethanol. The thawed sample was sonificated, 300 U DNAse was added and 
the sample was incubated for 45 minutes at room temperature. 
Inclusion bodies were isolated from the cell lysate by centrifugation at 12,000 g for 15 minutes. after 3 wahes in 50 
mM Tris?HCl, l mM DTT, pH 8.0 inclusion bodies were dissolved in 10 ml 8 M ureum, 1 mM DTT, 40 mM 
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Tris/HCl, 10% glycerol (v/v), pH 7.6. 
Preparative SDS electrophoresis was used to isolate recombinant transferrins fro bacterial components. This was 
performed with a model 392 BioRad Prep CelL 
Renaturation of recombinant human transferrrin 
Purified recombinant human transferrin was diluted with thoroughly degassed elution buffer to a final concentration of 
approximately 5 j..tg/ml. 0.1 MM EDT A, 40 mM KCI, 5 mM DTT and I mM GSH were added and pH was adjusted to 
8.2. Incubation at 37 oc for 30 minutes followed and the solution was subsequently kept at 0 oc for 50 minutes. After 
this, 0.5 mM GSSG was added and the solution was placed at 22 °C for four hours. The renaturation was performed 
under an atmosphere of nitrogen. 
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Appendix B: Addendum results 
Table 8'. Standard deviations of proportional distribution of transferrin subtractions in groups as 
defined in table 6. 
Group mono di tri tetra penta hex a he pta 
M 0.0 0.2 0.8 1.6 1.1 0.7 0.0 
c 0.0 0.4 1.0 2.2 1.2 0.7 0.0 
I 0.0 0.8 1.7 1.6 1.9 0.9 O.I 
ll 0.0 0.6 1.4 1.8 1.4 0.4 0.4 
m 0.0 0.7 1.9 3.4 1.6 0.9 0.9 
AT 0.0 0.3 0.9 3.0 1.2 0.5 0.5 
pp 0.0 0.8 1.1 2.2 1.2 0.3 0.2 
PPM 0.0 0.4 1.7 1.8 1.1 O.I 0.1 
Fe O.I 0.6 1.1 3.2 2.2 1.1 0.4 
OAC 0.0 0.2 0.7 1.2 0.8 0.6 0.2 
RA-NA 0.0 0.5 1.4 1.5 2.3 0.5 0.2 
RA-Fe 0.0 0.5 1.3 3.3 2.8 2.0 0.4 
RA-ACD 0.0 0.3 1.0 3.3 1.7 1.7 0.4 
Table 9'. Standard deviations of concentrations of transferrin subtractions in groups as defined in table 
6. Results in )lmoVL 
Group di tri tetra penta hexa he pta Total 
M 0.3 0.5 2.9 1.2 0.4 0.0 4.9 
c 0.2 0.4 1.7 0.7 0.3 0.0 2.4 
I 0.3 0.6 2.8 1.0 0.5 0.0 3.9 
n 0.5 0.8 5.3 2.2 1.2 0.2 9.4 
m 0.5 1.2 3.1 2.3 1.6 0.6 7.6 
AT 0.1 0.4 4.5 I.4 0.7 0.3 5.7 
pp 0.6 0.9 3.5 1.9 0.8 0.2 7.5 
PPM 0.2 0.9 2.4 1.9 0.3 0.0 3.6 
Fe 0.2 0.8 2.1 1.8 0.7 0.2 5.9 
OAC 0.1 0.4 2.8 1.2 0.3 0.2 4.8 
RA-NA 0.2 0.7 4.8 1.7 0.5 0.1 7.4 
RA-Fe 0.2 0.7 4.0 0.9 0.4 0.1 4.9 
RA-ACD O.I 0.3 2.8 1.2 0.5 0.1 4.5 
Table 11'. Standard deviations of iron uptake from transferrin by HepG2 cells ( pmol Fe /106 
cells I hr ). 
Transferrin fraction 
2 Sialo-transferrin 
4 Sial a-transferrin 
5 Sialo-transferrin 
6 Sialo-transfenin 
total uptake 
0.12 
O.I3 
0.12 
0.11 
Tf R -mediated ASGPR-mediated 
uptake uptake 
0.08 0.07 
0.12 0.08 
O.I2 0.06 
0.11 0.03 
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Table 12'. Standard deviations of iron uptake from transferrin by rat hepatocytes ( pmol Fe I 106 
cells I hr ). 
Transferrin fraction 
4 Sialo-transferrin 
6 Sialo-transferrin 
total uptake 
0.08 
0.07 
Tf R-mediated uptake ASGPR-mediated uptake 
0.09 
0.09 
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0.03 
0.02 
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van Dijk hebben deze gemaakt dat ik uiteindelijk toch een inzicht in de materie heb kunnen 
verwerven die althans mijzelf tot tevredenheid kon stemmen. 
Nel de Jeu en Martin Kroos wil ik ook apart noemen, met dank voor hun uitstekende werk op 
het laboratorium van de afdeling Chemische Pathologie. 
Maarten de Smit heeft onze afdeling een grote dienst bewezen middels het tot expressie 
brengen van het humane transferrine gen in de E. coli, en wij hopen hiervan in de komende 
jaren de wetenschappelijke vruchten van te kunnen plukken. 
Paul Wilson dank ik voor zijn ondersteuning van mijn voornemen een extra wetenschappelijke 
stage in de opleiding in te plannen teneinde het laatste practische werk te kunnen uitvoeren, en 
ook voor zijn spoedige beoordeling van het inderhaast geschreven manuscript, hetgeen 
eveneens moge gelden voor Professor Koster en Professor van Dam. 
Rest mij nog Harrie te danken voor zijn hulp, meer dan eens tot in de nachtelijke uren, bij de 
daadwerkelijke totstandkoming van het drukwerk. 
Masha, Thomas, Mark en Iris zijn in de afgelopen jaren, vooral dankzij de liefhebbende zorg 
van Debora weinig tot last en tot vee! levenslust geweest. Zelfs het jaar in Engeland zij n jullie 
allen steeds dicht bij mij geweest, een ware familie. 
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